{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:40:47Z","timestamp":1793911247920,"version":"4.8.0"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04848-4","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:31:39Z","timestamp":1786437099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7319-8878","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"4848_CR1","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1097\/CM9.0000000000003902","volume":"138","author":"M Liu","year":"2025","unstructured":"Liu M, He X, Yang X, Wang Z. 2024 annual report on cardiovascular health and diseases in China: Data and trend. Chin Med J (Engl). 2025;138:3037\u20133049. https:\/\/doi.org\/10.1097\/CM9.0000000000003902","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4848_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jjcc.2025.06.004","volume":"87","author":"R Patel","year":"2026","unstructured":"Patel R, Patel D, Dani U, Kuperkar K. Nanoparticle-driven drug delivery system for cardiovascular treatment. J Cardiol. 2026;87(1):23\u201337. https:\/\/doi.org\/10.1016\/j.jjcc.2025.06.004.","journal-title":"J Cardiol"},{"key":"4848_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/biom14080960","volume":"14","author":"Y Gu","year":"2024","unstructured":"Gu Y, et al. Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment. Biomolecules. 2024;14:960. https:\/\/doi.org\/10.3390\/biom14080960.","journal-title":"Biomolecules"},{"key":"4848_CR4","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/molecules27185843","volume":"27","author":"S Iravani","year":"2022","unstructured":"Iravani S, Varma RS. Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases. Molecules. 2022;27:5843. https:\/\/doi.org\/10.3390\/molecules27185843.","journal-title":"Molecules"},{"key":"4848_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123199","author":"F Peng","year":"2024","unstructured":"Peng F, et al. Nanomedicine in cardiology: Precision drug delivery for enhanced patient outcomes. Life Sci. 2024;358:123199. https:\/\/doi.org\/10.1016\/j.lfs.2024.123199","journal-title":"Life Sci"},{"key":"4848_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","volume":"14","author":"AA Halwani","year":"2022","unstructured":"Halwani AA. Development of Pharmaceutical Nanomedicines: From the Bench to the Market. Pharmaceutics. 2022;14:106. https:\/\/doi.org\/10.3390\/pharmaceutics14010106.","journal-title":"Pharmaceutics"},{"key":"4848_CR7","doi-asserted-by":"publisher","first-page":"e2502315","DOI":"10.1002\/smll.202502315","volume":"21","author":"N Desai","year":"2025","unstructured":"Desai N, et al. Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape. Small. 2025;21:e2502315. https:\/\/doi.org\/10.1002\/smll.202502315.","journal-title":"Small"},{"key":"4848_CR8","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/nano10101970","volume":"10","author":"H Idrees","year":"2020","unstructured":"Idrees H, et al. A Review of Biodegradable Natural Polymer-Based Nanoparticles for Drug Delivery Applications. Nanomaterials. 2020;10:1970. https:\/\/doi.org\/10.3390\/nano10101970.","journal-title":"Nanomaterials"},{"key":"4848_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jconrel.2019.09.020","volume":"314","author":"HK Mandl","year":"2019","unstructured":"Mandl HK, et al. Optimizing biodegradable nanoparticle size for tissue-specific delivery. J Control Release. 2019;314:92\u2013101. https:\/\/doi.org\/10.1016\/j.jconrel.2019.09.020.","journal-title":"J Control Release"},{"issue":"3","key":"4848_CR10","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/pharmaceutics15030831","volume":"15","author":"J German-Cort\u00e9s","year":"2023","unstructured":"German-Cort\u00e9s J, Vilar-Hern\u00e1ndez M, Rafael D, Abasolo I, Andrade F. Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment. Pharmaceutics. 2023;15(3):831. https:\/\/doi.org\/10.3390\/pharmaceutics15030831.","journal-title":"Pharmaceutics"},{"key":"4848_CR11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/ph15091036","volume":"15","author":"HH Genedy","year":"2022","unstructured":"Genedy HH, Delair T, Montembault A. Chitosan Based MicroRNA Nanocarriers. Pharmaceuticals (Basel). 2022;15:1036. https:\/\/doi.org\/10.3390\/ph15091036.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4848_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2174\/0113816128337166241219081400","volume":"31","author":"A Das","year":"2025","unstructured":"Das A, et al. Solid Lipid Nanoparticles for the Management of Hypertension: Advancements and Challenges. Curr Pharm Des. 2025;31:1823\u20131843. https:\/\/doi.org\/10.2174\/0113816128337166241219081400","journal-title":"Curr Pharm Des"},{"key":"4848_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2147\/IJN.S276301","volume":"16","author":"SC Shrestha","year":"2021","unstructured":"Shrestha SC, et al. Formulation and Characterization of Phytostanol Ester Solid Lipid Nanoparticles for the Management of Hypercholesterolemia: An ex vivo Study. Int J Nanomed. 2021;16:1977\u20131992. https:\/\/doi.org\/10.2147\/IJN.S276301","journal-title":"Int J Nanomed"},{"key":"4848_CR14","doi-asserted-by":"publisher","first-page":"3155962","DOI":"10.1155\/2021\/3155962","volume":"2021","author":"A Balkrishna","year":"2021","unstructured":"Balkrishna A, Kumar A, Arya V, Rohela A, Verma R, Nepovimova E, Krejcar O, Kumar D, Thakur N, Kuca K. Phytoantioxidant Functionalized Nanoparticles: A Green Approach to Combat Nanoparticle-Induced Oxidative Stress. Oxid Med Cell Longev. 2021;2021:3155962. https:\/\/doi.org\/10.1155\/2021\/3155962.","journal-title":"Oxid Med Cell Longev"},{"key":"4848_CR15","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.nano.2021.102433","volume":"36","author":"NK Younis","year":"2021","unstructured":"Younis NK, Ghoubaira JA, Bassil EP, Tantawi HN, Eid AH. Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine. 2021;36:102433. https:\/\/doi.org\/10.1016\/j.nano.2021.102433.","journal-title":"Nanomedicine"},{"key":"4848_CR16","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/pharmaceutics16101332","volume":"16","author":"J Georgeous","year":"2024","unstructured":"Georgeous J, AlSawaftah N, Abuwatfa WH, Husseini GA. Review of Gold Nanoparticles: Synthesis, Properties, Shapes, Cellular Uptake, Targeting, Release Mechanisms and Applications in Drug Delivery and Therapy. Pharmaceutics. 2024;16:1332. https:\/\/doi.org\/10.3390\/pharmaceutics16101332.","journal-title":"Pharmaceutics"},{"issue":"6","key":"4848_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s11307-025-02050-z","volume":"27","author":"E Mirhadi","year":"2025","unstructured":"Mirhadi E, Kesharwani P, Sukhorukov VN, Sahebkar A. Gold Nanoparticles in Atherosclerosis: A Dual Approach to Diagnosis and Therapy. Mol Imaging Biol. 2025;27(6):894\u2013913. https:\/\/doi.org\/10.1007\/s11307-025-02050-z.","journal-title":"Mol Imaging Biol"},{"key":"4848_CR18","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s10439-020-02474-4","volume":"48","author":"MJ Cheng","year":"2020","unstructured":"Cheng MJ, et al. Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity. Ann Biomed Eng. 2020;48:1941\u20131954. https:\/\/doi.org\/10.1007\/s10439-020-02474-4","journal-title":"Ann Biomed Eng"},{"key":"4848_CR19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/MS9.0000000000002867","volume":"87","author":"C Elendu","year":"2025","unstructured":"Elendu C, et al. Essential information about nanotechnology in cardiology. Ann Med Surg (Lond). 2025;87:748\u2013779. https:\/\/doi.org\/10.1097\/MS9.0000000000002867","journal-title":"Ann Med Surg (Lond)"},{"key":"4848_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1049\/nbt2.12081","volume":"16","author":"SH Hussein-Al-Ali","year":"2022","unstructured":"Hussein-Al-Ali SH, et al. Preparation and characterisation of ciprofloxacin-loaded silver nanoparticles for drug delivery. IET Nanobiotechnol. 2022;16:92\u2013101. https:\/\/doi.org\/10.1049\/nbt2.12081.","journal-title":"IET Nanobiotechnol"},{"issue":"8","key":"4848_CR21","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3390\/biomedicines11082201","volume":"11","author":"S Nikolova","year":"2023","unstructured":"Nikolova S, et al. Drug-Delivery Silver Nanoparticles: A New Perspective for Phenindione as an Anticoagulant. Biomedicines. 2023;11(8):2201. https:\/\/doi.org\/10.3390\/biomedicines11082201.","journal-title":"Biomedicines"},{"issue":"6","key":"4848_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/wnan.1414","volume":"8","author":"WJ Kelley","year":"2016","unstructured":"Kelley WJ, Safari H, Lopez-Cazares G, Eniola-Adefeso O. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016;8(6):909\u2013926. https:\/\/doi.org\/10.1002\/wnan.1414","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"4","key":"4848_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/156720110793360586","volume":"7","author":"C Antoniades","year":"2010","unstructured":"Antoniades C, Psarros C, Tousoulis D, Bakogiannis C, Shirodaria C, Stefanadis C. Nanoparticles: a promising therapeutic approach in atherosclerosis. Curr Drug Deliv. 2010;7(4):303\u2013311. https:\/\/doi.org\/10.2174\/156720110793360586","journal-title":"Curr Drug Deliv"},{"key":"4848_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fcvm.2017.00087","volume":"4","author":"S Katsuki","year":"2017","unstructured":"Katsuki S, Matoba T, Koga JI, Nakano K, Egashira K. Anti-inflammatory Nanomedicine for Cardiovascular Disease. Front Cardiovasc Med. 2017;4:87. https:\/\/doi.org\/10.3389\/fcvm.2017.00087.","journal-title":"Front Cardiovasc Med"},{"issue":"34","key":"4848_CR25","doi-asserted-by":"publisher","first-page":"38562","DOI":"10.1021\/acsami.2c11117","volume":"14","author":"L Yang","year":"2022","unstructured":"Yang L, Peng J, Shi A, Wang X, Li J, Su Y, Yin K, Zhao L, Zhao Y. Myocardium-Targeted Micelle Nanomedicine That Salvages the Heart from Ischemia\/Reperfusion Injury. ACS Appl Mater Interfaces. 2022;14(34):38562\u201338574. https:\/\/doi.org\/10.1021\/acsami.2c11117","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"4848_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/smll.201702793","volume":"14","author":"CKW Chan","year":"2018","unstructured":"Chan CKW, Zhang L, Cheng CK, Yang H, Huang Y, Tian XY, Choi CHJ. Recent Advances in Managing Atherosclerosis via Nanomedicine. Small. 2018;14(4):10. https:\/\/doi.org\/10.1002\/smll.201702793.","journal-title":"Small"},{"key":"4848_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijpharm.2019.01.023","volume":"558","author":"KX Tan","year":"2019","unstructured":"Tan KX, Pan S, Jeevanandam J, Danquah MK. Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers. Int J Pharm. 2019;558:413\u2013425. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.023","journal-title":"Int J Pharm"},{"key":"4848_CR28","doi-asserted-by":"publisher","first-page":"120677","DOI":"10.1016\/j.biomaterials.2021.120677","volume":"269","author":"LM Pham","year":"2021","unstructured":"Pham LM, Kim EC, Ou W, Phung CD, Nguyen TT, Pham TT, Poudel K, Gautam M, Nguyen HT, Jeong JH, Yong CS, Park SY, Kim JR, Kim JO. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials. 2021;269:120677. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120677.","journal-title":"Biomaterials"},{"issue":"6","key":"4848_CR29","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1021\/acsami.9b19036","volume":"12","author":"B Banik","year":"2020","unstructured":"Banik B, Surnar B, Askins BW, Banerjee M, Dhar S. Dual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases. ACS Appl Mater Interfaces. 2020;12(6):6852\u20136862. https:\/\/doi.org\/10.1021\/acsami.9b19036","journal-title":"ACS Appl Mater Interfaces"},{"key":"4848_CR30","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.mito.2025.102046","volume":"84","author":"Y He","year":"2025","unstructured":"He Y, Ren S, Liu C, Zheng X, Zhu C. Targeting mitochondrial quality control for myocardial ischemia-reperfusion injury. Mitochondrion. 2025;84:102046. https:\/\/doi.org\/10.1016\/j.mito.2025.102046.","journal-title":"Mitochondrion"},{"issue":"552","key":"4848_CR31","doi-asserted-by":"publisher","first-page":"eaaz7287","DOI":"10.1126\/scitranslmed.aaz7287","volume":"12","author":"A Pang","year":"2020","unstructured":"Pang A, Cheng N, Cui Y, Bai Y, Hong Z, Delaney MK, Zhang Y, Chang C, Wang C, Liu C, Plata PL, Zakharov A, Kabirov K, Rehman J, Skidgel RA, Malik AB, Liu Y, Lyubimov A, Gu M, Du X. High-loading G\u03b113-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia\/reperfusion injury. Sci Transl Med. 2020;12(552):eaaz7287. https:\/\/doi.org\/10.1126\/scitranslmed.aaz7287.","journal-title":"Sci Transl Med"},{"key":"4848_CR32","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","volume":"309","author":"M Dymek","year":"2022","unstructured":"Dymek M, Sikora E. Liposomes as biocompatible and smart delivery systems - the current state. Adv Colloid Interface Sci. 2022;309:102757. https:\/\/doi.org\/10.1016\/j.cis.2022.102757.","journal-title":"Adv Colloid Interface Sci"},{"key":"4848_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/membranes13040407","volume":"13","author":"AA Efimova","year":"2023","unstructured":"Efimova AA, et al. pH-Sensitive Liposomes with Embedded 3-(isobutylamino) cholan-24-oic Acid: What Is the Possible Mechanism of Fast Cargo Release? Membr (Basel). 2023;13:407. https:\/\/doi.org\/10.3390\/membranes13040407.","journal-title":"Membr (Basel)"},{"key":"4848_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/pharmaceutics13020267","volume":"13","author":"A Obinu","year":"2021","unstructured":"Obinu A, et al. Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption via Intestinal Lymphatic Transport. Pharmaceutics. 2021;13:267. https:\/\/doi.org\/10.3390\/pharmaceutics13020267.","journal-title":"Pharmaceutics"},{"key":"4848_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/10717544.2020.1754525","volume":"27","author":"X Liu","year":"2020","unstructured":"Liu X, et al. In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting. Drug Deliv. 2020;27:599\u2013606. https:\/\/doi.org\/10.1080\/10717544.2020.1754525.","journal-title":"Drug Deliv"},{"key":"4848_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.chemphyslip.2014.03.006","volume":"181","author":"E Rostami","year":"2014","unstructured":"Rostami E, et al. Drug targeting using solid lipid nanoparticles. Chem Phys Lipids. 2014;181:56\u201361. https:\/\/doi.org\/10.1016\/j.chemphyslip.2014.03.006.","journal-title":"Chem Phys Lipids"},{"key":"4848_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2018.01.046","volume":"164","author":"A Nakhlband","year":"2018","unstructured":"Nakhlband A, et al. Marrubiin-loaded solid lipid nanoparticles\u2019 impact on TNF-\u03b1 treated umbilical vein endothelial cells: A study for cardioprotective effect. Colloids Surf B Biointerfaces. 2018;164:299\u2013307. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.01.046.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4848_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biopha.2017.02.029","volume":"89","author":"Z Dong","year":"2017","unstructured":"Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297\u2013304. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.029.","journal-title":"Biomed Pharmacother"},{"key":"4848_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P. Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: Comp Rev Pharm. 2023;15:1593. https:\/\/doi.org\/10.3390\/pharmaceutics15061593.","journal-title":"Nanostructured Lipid Carriers: Comp Rev Pharm"},{"key":"4848_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/03639045.2019.1569023","volume":"45","author":"P Jansook","year":"2019","unstructured":"Jansook P, F\u00fcl\u00f6p Z, Ritthidej GC. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. Drug Dev Ind Pharm. 2019;45:560\u2013567. https:\/\/doi.org\/10.1080\/03639045.2019.1569023","journal-title":"Drug Dev Ind Pharm"},{"key":"4848_CR41","doi-asserted-by":"publisher","first-page":"137291","DOI":"10.1016\/j.foodchem.2023.137291","volume":"433","author":"L Hanley","year":"2024","unstructured":"Hanley L, Ghazani SM, Marangoni AG. Giant multilamellar and large unilamellar lecithin vesicles for the encapsulation and oral delivery of cannabinoids. Food Chem. 2024;433:137291. https:\/\/doi.org\/10.1016\/j.foodchem.2023.137291","journal-title":"Food Chem"},{"issue":"1","key":"4848_CR42","doi-asserted-by":"publisher","first-page":"29931","DOI":"10.1038\/s41598-024-80970-6","volume":"14","author":"AG Marangoni","year":"2024","unstructured":"Marangoni AG, Pensini E. Spontaneous nanosized liposome formation from crude dried lecithin upon addition of glycerol. Sci Rep. 2024;14(1):29931. https:\/\/doi.org\/10.1038\/s41598-024-80970-6.","journal-title":"Sci Rep"},{"issue":"5","key":"4848_CR43","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394.","journal-title":"Heliyon"},{"key":"4848_CR44","doi-asserted-by":"publisher","first-page":"9845459","DOI":"10.34133\/2022\/9845459","volume":"2022","author":"L Chen","year":"2022","unstructured":"Chen L, et al. Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy. Res (Wash D C). 2022;2022:9845459. https:\/\/doi.org\/10.34133\/2022\/9845459.","journal-title":"Res (Wash D C)"},{"key":"4848_CR45","doi-asserted-by":"publisher","first-page":"176969","DOI":"10.1016\/j.ejphar.2024.176969","volume":"982","author":"P Choudhury","year":"2024","unstructured":"Choudhury P, Kandula N, Kosuru R, Adena SKR, Nanomedicine. A great boon for cardiac regenerative medicine. Eur J Pharmacol. 2024;982:176969. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176969.","journal-title":"Eur J Pharmacol"},{"key":"4848_CR46","doi-asserted-by":"publisher","first-page":"122364","DOI":"10.1016\/j.biomaterials.2023.122364","volume":"302","author":"X Wang","year":"2023","unstructured":"Wang X, Shi H, Huang S, Zhang Y, He X, Long Q, Qian B, Zhong Y, Qi Z, Zhao Q, Ye X. Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction. Biomaterials. 2023;302:122364. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122364.","journal-title":"Biomaterials"},{"key":"4848_CR47","doi-asserted-by":"publisher","first-page":"1013910","DOI":"10.3389\/fchem.2022.1013910","volume":"10","author":"L You","year":"2022","unstructured":"You L, et al. Precise dapagliflozin delivery by cardiac homing peptide functionalized mesoporous silica nanocarriers for heart failure repair after myocardial infarction. Front Chem. 2022;10:1013910. . https:\/\/doi.org\/10.3389\/fchem.2022.1013910","journal-title":"Front Chem"},{"key":"4848_CR48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.nano.2017.12.019","volume":"14","author":"Z Wei","year":"2018","unstructured":"Wei Z, et al. The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk. Nanomedicine. 2018;14:673\u2013684. https:\/\/doi.org\/10.1016\/j.nano.2017.12.019","journal-title":"Nanomedicine"},{"key":"4848_CR49","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1039\/d4bm00415a","volume":"12","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li C, Yang X, Yang B, Fu Q. Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics. Biomaterials Sci. 2024;12:3805\u20133825. https:\/\/doi.org\/10.1039\/d4bm00415a","journal-title":"Biomaterials Sci"},{"key":"4848_CR50","doi-asserted-by":"publisher","first-page":"e2202169","DOI":"10.1002\/adma.202202169","volume":"34","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease. Adv Mater. 2022;34:e2202169. https:\/\/doi.org\/10.1002\/adma.202202169.","journal-title":"Adv Mater"},{"key":"4848_CR51","doi-asserted-by":"publisher","first-page":"104014","DOI":"10.1016\/j.drudis.2024.104014","volume":"29","author":"Y Wei","year":"2024","unstructured":"Wei Y, Lv J, Zhu S, Wang S, Su J, Xu C. Enzyme-responsive liposomes for controlled drug release. Drug Discov Today. 2024;29:104014. https:\/\/doi.org\/10.1016\/j.drudis.2024.104014.","journal-title":"Drug Discov Today"},{"key":"4848_CR52","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ijbiomac.2022.09.116","volume":"220","author":"A Balde","year":"2022","unstructured":"Balde A, Kim SK, Benjakul S, Nazeer RA. Pulmonary drug delivery applications of natural polysaccharide polymer derived nano\/micro-carrier systems: A review. Int J Biol Macromol. 2022;220:1464\u20131479. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.09.116","journal-title":"Int J Biol Macromol"},{"key":"4848_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","volume":"159","author":"M Mir","year":"2017","unstructured":"Mir M, Ahmed N, Rehman AU. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces. 2017;159:217\u2013231. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.07.038","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4848_CR54","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, et al. Polymeric Nanoparticles for Drug Delivery. Chem Rev. 2024;124:5505\u20135616. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705","journal-title":"Chem Rev"},{"issue":"16","key":"4848_CR55","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A, Souto EB. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules. 2020;25(16):3731. https:\/\/doi.org\/10.3390\/molecules25163731.","journal-title":"Molecules"},{"key":"4848_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/polym16020290","volume":"16","author":"M Chountoulesi","year":"2024","unstructured":"Chountoulesi M, Pippa N, Forys A, Trzebicka B, Pispas S. Structure-Based Evaluation of Hybrid Lipid-Polymer Nanoparticles: The Role of the Polymeric Guest. Polym (Basel). 2024;16:290. https:\/\/doi.org\/10.3390\/polym16020290.","journal-title":"Polym (Basel)"},{"key":"4848_CR57","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1007\/s00216-024-05576-3","volume":"416","author":"J Klangprapan","year":"2024","unstructured":"Klangprapan J, Sudjarwo WAA, Lieberzeit PA, Choowongkomon K. Synthesis and characterization of molecularly imprinted polymer nanoparticles against porcine circovirus type 2 viral-like particles. Anal Bioanal Chem. 2024;416:7357\u20137368. https:\/\/doi.org\/10.1007\/s00216-024-05576-3","journal-title":"Anal Bioanal Chem"},{"key":"4848_CR58","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.1021\/acsami.8b22732","volume":"11","author":"J Xu","year":"2019","unstructured":"Xu J, et al. Molecularly Imprinted Polymer Nanoparticles as Potential Synthetic Antibodies for Immunoprotection against HIV. ACS Appl Mater Interfaces. 2019;11:9824\u20139831. https:\/\/doi.org\/10.1021\/acsami.8b22732","journal-title":"ACS Appl Mater Interfaces"},{"issue":"Pt A","key":"4848_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"4848_CR60","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.3390\/ijms26073102","volume":"26","author":"D Makharadze","year":"2025","unstructured":"Makharadze D, Del Valle LJ, Katsarava R, Puiggal\u00ed J. The Art of PEGylation: From Simple Polymer to Sophisticated Drug Delivery System. Int J Mol Sci. 2025;26(7):3102. https:\/\/doi.org\/10.3390\/ijms26073102.","journal-title":"Int J Mol Sci"},{"key":"4848_CR61","doi-asserted-by":"publisher","first-page":"1349077","DOI":"10.3389\/fbioe.2024.1349077","volume":"12","author":"L Jiao","year":"2024","unstructured":"Jiao L, Sun Z, Sun Z, Liu J, Deng G, Wang X. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases. Front Bioeng Biotechnol. 2024;12:1349077. https:\/\/doi.org\/10.3389\/fbioe.2024.1349077.","journal-title":"Front Bioeng Biotechnol"},{"key":"4848_CR62","doi-asserted-by":"publisher","first-page":"118997","DOI":"10.1016\/j.ijpharm.2019.118997","volume":"576","author":"HC Quadros","year":"2020","unstructured":"Quadros HC, Santos LMF, Meira CS, Khouri MI, Mattei B, Soares MBP, de Castro-Borges W, Farias LP, Formiga FR. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis. Int J Pharm. 2020;576:118997. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118997.","journal-title":"Int J Pharm"},{"issue":"3","key":"4848_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1039\/d5bm01624j","volume":"14","author":"RR Nair","year":"2026","unstructured":"Nair RR, R\u00e5berg L, M\u00e5rtensson H, Jia F, Gu Y, Yakubu H, Erensoy G, Stubelius A. Advances in phenylboronic acid and phenylboronic ester-based responsive systems for precision medicine. Biomater Sci. 2026;14(3):661\u2013683. https:\/\/doi.org\/10.1039\/d5bm01624j","journal-title":"Biomater Sci"},{"key":"4848_CR64","doi-asserted-by":"publisher","first-page":"115972","DOI":"10.1016\/j.carbpol.2020.115972","volume":"236","author":"Z Yu","year":"2020","unstructured":"Yu Z, Ma L, Ye S, Li G, Zhang M. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress. Carbohydr Polym. 2020;236:115972. https:\/\/doi.org\/10.1016\/j.carbpol.2020.115972.","journal-title":"Carbohydr Polym"},{"issue":"12","key":"4848_CR65","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/pharmaceutics17121613","volume":"17","author":"MM Stevanovi\u0107","year":"2025","unstructured":"Stevanovi\u0107 MM, Qian K, Huang L, Vukomanovi\u0107 M. PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances. Pharmaceutics. 2025;17(12):1613. https:\/\/doi.org\/10.3390\/pharmaceutics17121613.","journal-title":"Pharmaceutics"},{"key":"4848_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12951-021-00863-y","volume":"19","author":"T Yin","year":"2021","unstructured":"Yin T, et al. Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE-\/- mice. J Nanobiotechnol. 2021;19:121. https:\/\/doi.org\/10.1186\/s12951-021-00863-y.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4848_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057","journal-title":"Pharmaceutics"},{"key":"4848_CR68","doi-asserted-by":"publisher","first-page":"20765","DOI":"10.1038\/s41598-025-06872-3","volume":"15","author":"S Alqarni","year":"1038","unstructured":"Alqarni S, Huwaimel B. Predicting PLGA nanoparticle size and zeta potential in synthesis for application of drug delivery via machine learning analysis. Sci Rep. 2025;15(1):20765. https:\/\/doi.org\/10.1038\/s41598-025-06872-3","journal-title":"Sci Rep"},{"issue":"3","key":"4848_CR69","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377\u20131397. https:\/\/doi.org\/10.3390\/polym3031377","journal-title":"Polymers"},{"key":"4848_CR70","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1021\/acsanm.8b01099","volume":"1","author":"CL Meisel","year":"2018","unstructured":"Meisel CL, Bainbridge P, Mitsouras D, Wong JY. Targeted Nanoparticle Binding to Hydroxyapatite in a High Serum Environment for Early Detection of Heart Disease. ACS Appl Nano Mater. 2018;1:4927\u20134939. https:\/\/doi.org\/10.1021\/acsanm.8b01099","journal-title":"ACS Appl Nano Mater"},{"key":"4848_CR71","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/FJC.0000000000000885","volume":"76","author":"B Qian","year":"2020","unstructured":"Qian B, Zhao Q, Ye X. Ultrasound and Magnetic Responsive Drug Delivery Systems for Cardiovascular Application. J Cardiovasc Pharmacol. 2020;76:414\u2013426. https:\/\/doi.org\/10.1097\/FJC.0000000000000885","journal-title":"J Cardiovasc Pharmacol"},{"key":"4848_CR72","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1021\/ar200023x","volume":"44","author":"R Bardhan","year":"2011","unstructured":"Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res. 2011;44:936\u2013946. https:\/\/doi.org\/10.1021\/ar200023x","journal-title":"Acc Chem Res"},{"key":"4848_CR73","doi-asserted-by":"publisher","first-page":"26416","DOI":"10.1021\/acsami.5c02882","volume":"17","author":"H Zhu","year":"2025","unstructured":"Zhu H, et al. Multifunctional Mesoporous Silicon Nanoparticles for MRI-Based Diagnostic Imaging and Glioma Therapy. ACS Appl Mater Interfaces. 2025;17:26416\u201326430. https:\/\/doi.org\/10.1021\/acsami.5c02882","journal-title":"ACS Appl Mater Interfaces"},{"key":"4848_CR74","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.clinthera.2023.08.017","volume":"45","author":"H Kirla","year":"2023","unstructured":"Kirla H, Henry DJ, Jansen S, Thompson PL, Hamzah J. Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease. Clin Ther. 2023;45:1060\u20131068. https:\/\/doi.org\/10.1016\/j.clinthera.2023.08.017","journal-title":"Clin Ther"},{"issue":"6","key":"4848_CR75","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1021\/acsnano.9b00653","volume":"13","author":"F Chen","year":"2019","unstructured":"Chen F, Zhao ER, Hableel G, Hu T, Kim T, Li J, Gonzalez-Pech NI, Cheng DJ, Lemaster JE, Xie Y, Grassian VH, Sen GL, Jokerst JV. Increasing the Efficacy of Stem Cell Therapy via Triple-Function Inorganic Nanoparticles. ACS Nano. 2019;13(6):6605\u20136617. https:\/\/doi.org\/10.1021\/acsnano.9b00653","journal-title":"ACS Nano"},{"issue":"17","key":"4848_CR76","doi-asserted-by":"publisher","first-page":"2308298","DOI":"10.1002\/advs.202308298","volume":"11","author":"S Wang","year":"2024","unstructured":"Wang S, He H, Mao Y, Zhang Y, Gu N. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles. Adv Sci. 2024;11(17):2308298. https:\/\/doi.org\/10.1002\/advs.202308298.","journal-title":"Adv Sci"},{"issue":"1","key":"4848_CR77","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, et al. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct Target Ther. 2023;8(1):435. https:\/\/doi.org\/10.1038\/s41392-023-01654-7","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4848_CR78","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","volume":"119","author":"J Wahsner","year":"2018","unstructured":"Wahsner J, et al. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers. Chem Rev. 2019;119(2):957\u20131057. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00363","journal-title":"Chem Rev"},{"issue":"9","key":"4848_CR79","doi-asserted-by":"publisher","first-page":"e202400087","DOI":"10.1002\/tcr.202400087","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Y, Lu Y, Li J. Biomimetic Nanoparticles for the Diagnosis and Therapy of Atherosclerosis. Chem record (New York N Y). 2024;24(9):e202400087. https:\/\/doi.org\/10.1002\/tcr.202400087.","journal-title":"Chem record (New York N Y)"},{"key":"4848_CR80","doi-asserted-by":"publisher","first-page":"112464","DOI":"10.1016\/j.colsurfb.2022.112464","volume":"214","author":"M Yin","year":"2022","unstructured":"Yin M, et al. Platelet membrane-cloaked selenium\/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy. Colloids Surf B Biointerfaces. 2022;214:112464. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112464.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4848_CR81","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cvr\/cvaf039","volume":"121","author":"Q Chen","year":"2025","unstructured":"Chen Q, Yu Y, Tong L, Weiss RM, Wei SG. Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling. Cardiovasc Res. 2025;121:760\u2013774. https:\/\/doi.org\/10.1093\/cvr\/cvaf039","journal-title":"Cardiovasc Res"},{"issue":"7","key":"4848_CR82","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/biomedicines13071720","volume":"13","author":"D Bartusik-Aebisher","year":"2025","unstructured":"Bartusik-Aebisher D, Podg\u00f3rski R, Serafin I, Aebisher D. Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies. Biomedicines. 2025;13(7):1720. https:\/\/doi.org\/10.3390\/biomedicines13071720.","journal-title":"Biomedicines"},{"key":"4848_CR83","doi-asserted-by":"publisher","first-page":"1037741","DOI":"10.3389\/fcvm.2022.1037741","volume":"9","author":"Y Gong","year":"2023","unstructured":"Gong Y, Liu H, Ke S, Zhuo L, Wang H. Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease. Front Cardiovasc Med. 2023;9:1037741. https:\/\/doi.org\/10.3389\/fcvm.2022.1037741.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"4848_CR84","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.3390\/molecules26113428","volume":"26","author":"C Zhu","year":"2021","unstructured":"Zhu C, Ma J, Ji Z, Shen J, Wang Q. Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders. Molecules. 2021;26(11):3428. https:\/\/doi.org\/10.3390\/molecules26113428.","journal-title":"Molecules"},{"key":"4848_CR85","doi-asserted-by":"publisher","unstructured":"Nestele JA, Rohlfing AK, Dicenta V et al. Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation. Int J Mol Sci. 2021,23(1):11 Published 2021 Dec 21. https:\/\/doi.org\/10.3390\/ijms23010011","DOI":"10.3390\/ijms23010011"},{"issue":"3","key":"4848_CR86","doi-asserted-by":"publisher","first-page":"e20230015","DOI":"10.1002\/SMMD.20230015","volume":"2","author":"Y Li","year":"2023","unstructured":"Li Y, Wang J, Xie J. Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy. Smart Med. 2023;2(3):e20230015. https:\/\/doi.org\/10.1002\/SMMD.20230015.","journal-title":"Smart Med"},{"issue":"4","key":"4848_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10856-023-06719-1","volume":"34","author":"Z Xu","year":"2023","unstructured":"Xu Z, Huang J, Zhang T, Xu W, Liao X, Wang Y, Wang G. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy. J Mater Sci: Mater Med. 2023;34(4):18. https:\/\/doi.org\/10.1007\/s10856-023-06719-1.","journal-title":"J Mater Sci: Mater Med"},{"issue":"18","key":"4848_CR88","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.3390\/ijms26188884","volume":"26","author":"C Choi","year":"2025","unstructured":"Choi C, Rhee WJ. Targeted Atherosclerosis Treatment Using Vascular Cell Adhesion Molecule-1 Targeting Peptide-Engineered Plant-Derived Extracellular Vesicles. Int J Mol Sci. 2025;26(18):8884. https:\/\/doi.org\/10.3390\/ijms26188884.","journal-title":"Int J Mol Sci"},{"key":"4848_CR89","doi-asserted-by":"publisher","unstructured":"Zhao X, Chen W, Wu J, Shen Y, Xu B, Chen Z, Sun Y. Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases. Int J Nanomed. 2025;20:8249\u20138289. https:\/\/doi.org\/10.2147\/IJN.S531558","DOI":"10.2147\/IJN.S531558"},{"key":"4848_CR90","doi-asserted-by":"publisher","unstructured":"Jiang Y, Yu M, Song ZF, Wei ZY, Huang J, Qian HY. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomed. 2024;19:2553\u20132571. https:\/\/doi.org\/10.2147\/IJN.S452824","DOI":"10.2147\/IJN.S452824"},{"key":"4848_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2026.01.029","volume":"213","author":"J Zhang","year":"2026","unstructured":"Zhang J, Tao S, Yang J, Fu P, Chen Z, Rao L, Tao S, He Y. Cell membrane-coated nanoparticles target multiorgan crosstalk in cardiovascular-kidney-metabolic syndrome. Acta Biomater. 2026;213:1\u201320. https:\/\/doi.org\/10.1016\/j.actbio.2026.01.029.","journal-title":"Acta Biomater"},{"key":"4848_CR92","doi-asserted-by":"publisher","first-page":"e2205062","DOI":"10.1002\/smll.202205062","volume":"18","author":"C Huang","year":"2022","unstructured":"Huang C, et al. Biodegradable Redox-Responsive AIEgen-Based-Covalent Organic Framework Nanocarriers for Long-Term Treatment of Myocardial Ischemia\/Reperfusion Injury. Small. 2022;18:e2205062. https:\/\/doi.org\/10.1002\/smll.202205062.","journal-title":"Small"},{"key":"4848_CR93","doi-asserted-by":"publisher","first-page":"e2407191","DOI":"10.1002\/smll.20240719","volume":"21","author":"M Zhou","year":"2025","unstructured":"Zhou M, et al. Biomimetic Nano-delivery of Small-Molecule Piceatannol Modulates Tumor Stemness and Suppresses Colorectal Cancer Metastasis via Hippo\/YAP1\/SOX9 Signaling. Small. 2025;21:e2407191. https:\/\/doi.org\/10.1002\/smll.20240719.","journal-title":"Small"},{"key":"4848_CR94","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1021\/acs.biomac.3c00421","volume":"24","author":"HL Sullivan","year":"2023","unstructured":"Sullivan HL, et al. Enzyme-Responsive Nanoparticles for the Targeted Delivery of an MMP Inhibitor to Acute Myocardial Infarction. Biomacromolecules. 2023;24:4695\u20134704. https:\/\/doi.org\/10.1021\/acs.biomac.3c00421","journal-title":"Biomacromolecules"},{"key":"4848_CR95","doi-asserted-by":"publisher","first-page":"2288797","DOI":"10.1080\/10717544.2023.2288797","volume":"30","author":"M Li","year":"2023","unstructured":"Li M, Guo Q, Zhong C, Zhang Z. Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective. Drug Deliv. 2023;30:2288797. https:\/\/doi.org\/10.1080\/10717544.2023.2288797.","journal-title":"Drug Deliv"},{"key":"4848_CR96","doi-asserted-by":"publisher","first-page":"122678","DOI":"10.1016\/j.biomaterials.2024.122678","volume":"311","author":"Y Xia","year":"2024","unstructured":"Xia Y, et al. Invasive metastatic tumor-camouflaged ROS responsive nanosystem for targeting therapeutic brain injury after cardiac arrest. Biomaterials. 2024;311:122678. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122678.","journal-title":"Biomaterials"},{"issue":"23","key":"4848_CR97","doi-asserted-by":"publisher","first-page":"e1706759","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell Membrane Coating Nanotechnology. Adv Mater. 2018;30(23):e1706759. https:\/\/doi.org\/10.1002\/adma.201706759.","journal-title":"Adv Mater"},{"key":"4848_CR98","doi-asserted-by":"publisher","unstructured":"Liu L et al. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat Commun 2021;12(1):5726. https:\/\/doi.org\/10.1038\/s41467-021-26052-x","DOI":"10.1038\/s41467-021-26052-x"},{"key":"4848_CR99","doi-asserted-by":"publisher","unstructured":"Hu CMJ et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 2011;108 (27):10980\u201310985. https:\/\/doi.org\/10.1073\/pnas.1106634108","DOI":"10.1073\/pnas.1106634108"},{"issue":"12","key":"4848_CR100","doi-asserted-by":"publisher","first-page":"13759","DOI":"10.1021\/acsnano.8b08875","volume":"13","author":"TJ Beldman","year":"2019","unstructured":"Beldman TJ, Malinova TS, Desclos E, Grootemaat AE, Misiak ALS, van der Velden S, van Roomen CPAA, Beckers L, van Veen HA, Krawczyk PM, Hoebe RA, Sluimer JC, Neele AE, de Winther MPJ, van der Wel NN, Lutgens E, Mulder WJM, Huveneers S, Kluza E. Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy. ACS Nano. 2019;13(12):13759\u201313774. https:\/\/doi.org\/10.1021\/acsnano.8b08875","journal-title":"ACS Nano"},{"issue":"3","key":"4848_CR101","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13346-015-0220-8","volume":"5","author":"ML Briuglia","year":"2015","unstructured":"Briuglia ML, Rotella C, McFarlane A, Lamprou DA. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015;5(3):231\u2013242. https:\/\/doi.org\/10.1007\/s13346-015-0220-8","journal-title":"Drug Deliv Transl Res"},{"issue":"9","key":"4848_CR102","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/pharmaceutics13091365","volume":"13","author":"KK Ewert","year":"2021","unstructured":"Ewert KK, Scodeller P, Sim\u00f3n-Gracia L, Steffes VM, Wonder EA, Teesalu T, Safinya CR. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics. Pharmaceutics. 2021;13(9):1365. https:\/\/doi.org\/10.3390\/pharmaceutics13091365.","journal-title":"Pharmaceutics"},{"key":"4848_CR103","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.mtbio.2025.102205","volume":"34","author":"X Wang","year":"2025","unstructured":"Wang X, Zhong Y, Qian B, Huang S, Long Q, Zhang H, Zhao Q, Ye X. Self-assembled extracellular matrix-lipid nanoparticle composite for site-specific siRNA delivery to improve cardiac repair post-myocardial infarction. Mater Today Bio. 2025;34:102205. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102205.","journal-title":"Mater Today Bio"},{"issue":"11","key":"4848_CR104","doi-asserted-by":"publisher","first-page":"e2307800120","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Kon E, Sharma P, Peer D. Endosomal escape: A bottleneck for LNP-mediated therapeutics. Proc Natl Acad Sci U S A. 2024;121(11):e2307800120. https:\/\/doi.org\/10.1073\/pnas.2307800120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4848_CR105","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00210-023-02670-8","volume":"397","author":"HA Simrah","year":"2024","unstructured":"Simrah HA, Usmani SA, Izhar MP. Transfersome, an ultra-deformable lipid-based drug nanocarrier: an updated review with therapeutic applications. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(2):639\u2013673. https:\/\/doi.org\/10.1007\/s00210-023-02670-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"4848_CR106","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11095-018-2429-y","volume":"35","author":"M Kanamala","year":"2018","unstructured":"Kanamala M, Palmer BD, Ghandehari H, Wilson WR, Wu Z. PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation. Pharm Res. 2018;35(8):154. https:\/\/doi.org\/10.1007\/s11095-018-2429-y.","journal-title":"Pharm Res"},{"issue":"11","key":"4848_CR107","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1080\/17425247.2025.2556013","volume":"22","author":"MB Mustafa","year":"2025","unstructured":"Mustafa MB, Lou J, Best MD. Development of ROS-responsive liposomes toward targeted drug delivery. Expert Opin Drug Deliv. 2025;22(11):1709\u20131725. https:\/\/doi.org\/10.1080\/17425247.2025.2556013","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"4848_CR108","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/btm2.10050","volume":"2","author":"RL Manthe","year":"2017","unstructured":"Manthe RL, Muro S. ICAM-1-Targeted Nanocarriers Attenuate Endothelial Release of Soluble ICAM-1, an Inflammatory Regulator. Bioeng Transl Med. 2017;2(1):109\u2013119. https:\/\/doi.org\/10.1002\/btm2.10050","journal-title":"Bioeng Transl Med"},{"key":"4848_CR109","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1039\/d3bm00857f","volume":"11","author":"W Lei","year":"2023","unstructured":"Lei W, et al. Synergetic EGCG and coenzyme Q10 DSPC liposome nanoparticles protect against myocardial infarction. Biomater Sci. 2023;11:6862\u20136870. https:\/\/doi.org\/10.1039\/d3bm00857f","journal-title":"Biomater Sci"},{"key":"4848_CR110","doi-asserted-by":"publisher","unstructured":"Ma Q, Zhang WD, Li Y, etal. Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system. Eur Heart J. 2023,44(Suppl 2):ehad655.1306. https:\/\/doi.org\/10.1093\/eurheartj\/ehad655.1306","DOI":"10.1093\/eurheartj\/ehad655.1306"},{"key":"4848_CR111","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/08853282221087102","volume":"37","author":"F Gao","year":"2022","unstructured":"Gao F, et al. Mitochondrial targeted astaxanthin liposomes for myocardial ischemia-reperfusion injury based on oxidative stress. J Biomater Appl. 2022;37:303\u2013314. https:\/\/doi.org\/10.1177\/08853282221087102","journal-title":"J Biomater Appl"},{"key":"4848_CR112","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00604-023-05888-8","volume":"190","author":"B Radwan","year":"2023","unstructured":"Radwan B, et al. Uptake and anti-inflammatory effects of liposomal astaxanthin on endothelial cells tracked by Raman and fluorescence imaging. Mikrochim Acta. 2023;190:332. https:\/\/doi.org\/10.1007\/s00604-023-05888-8.","journal-title":"Mikrochim Acta"},{"issue":"1","key":"4848_CR113","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jps.20737","volume":"96","author":"D Mishra","year":"2007","unstructured":"Mishra D, Garg M, Dubey V, Jain S, Jain NK. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci. 2007;96(1):145\u2013155. https:\/\/doi.org\/10.1002\/jps.20737","journal-title":"J Pharm Sci"},{"issue":"9","key":"4848_CR114","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1080\/03639045.2019.1634091","volume":"45","author":"N Ramesh","year":"2019","unstructured":"Ramesh N, Mandal AKA. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model. Drug Dev Ind Pharm. 2019;45(9):1506\u20131514. https:\/\/doi.org\/10.1080\/03639045.2019.1634091","journal-title":"Drug Dev Ind Pharm"},{"key":"4848_CR115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2016.05.049","volume":"235","author":"Y Dou","year":"2016","unstructured":"Dou Y, Guo J, Chen Y, Han S, Xu X, Shi Q, Jia Y, Liu Y, Deng Y, Wang R, Li X, Zhang J. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice. J Control Release. 2016;235:48\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.049.","journal-title":"J Control Release"},{"issue":"30","key":"4848_CR116","doi-asserted-by":"publisher","first-page":"e2401466","DOI":"10.1002\/adhm.202401466","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Qi H, Zong J, Li M, Yang Y, Li X, Li T, Cho JY, Yu T. Oral Piwi-Interacting RNA Delivery Mediated by Green Tea-Derived Exosome-Like Nanovesicles for the Treatment of Aortic Dissection. Adv Healthc Mater. 2024;13(30):e2401466. https:\/\/doi.org\/10.1002\/adhm.202401466.","journal-title":"Adv Healthc Mater"},{"key":"4848_CR117","doi-asserted-by":"publisher","first-page":"9407","DOI":"10.2147\/IJN.S522157","volume":"20","author":"S Xu","year":"2025","unstructured":"Xu S, Zeng Y, Tan X, Zhang G, Xu A, Fan H, Yu F, Qin Z, Song Y, Jiang Y, Wang X, Zhang D, Nong Y, Lian D, Tang J, Zhou Y. Targeted Delivery of Exosome-Derived miRNA-185-5p Inhibitor via Liposomes Alleviates Apoptosis and Cuproptosis in Dilated Cardiomyopathy. Int J Nanomed. 2025;20:9407\u20139425. https:\/\/doi.org\/10.2147\/IJN.S522157","journal-title":"Int J Nanomed"},{"key":"4848_CR118","doi-asserted-by":"publisher","first-page":"109480","DOI":"10.1016\/j.biopha.2019.109480","volume":"120","author":"J Guo","year":"2019","unstructured":"Guo J, et al. Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother. 2019;120:109480. https:\/\/doi.org\/10.1016\/j.biopha.2019.109480.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4848_CR119","doi-asserted-by":"publisher","first-page":"e1737","DOI":"10.1002\/wnan.1737","volume":"13","author":"H He","year":"2021","unstructured":"He H, Hong K, Liu L, Schwendeman A. Artificial high-density lipoprotein-mimicking nanotherapeutics for the treatment of cardiovascular diseases. Wiley interdisciplinary reviews. Nanomed Nanobiotechnol. 2021;13(6):e1737. https:\/\/doi.org\/10.1002\/wnan.1737.","journal-title":"Nanomed Nanobiotechnol"},{"key":"4848_CR120","doi-asserted-by":"publisher","first-page":"123009","DOI":"10.1016\/j.ijpharm.2023.123009","volume":"640","author":"R Dash","year":"2023","unstructured":"Dash R, Yadav M, Biswal J, Chandra A, Goel VK, Sharma T, Prusty SK, Mohapatra S. Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis. Int J Pharm. 2023;640:123009. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123009.","journal-title":"Int J Pharm"},{"issue":"9","key":"4848_CR121","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3390\/pharmaceutics14091840","volume":"14","author":"AE Caprifico","year":"2022","unstructured":"Caprifico AE, Foot PJS, Polycarpou E, Calabrese G. Advances in Chitosan-Based CRISPR\/Cas9 Delivery Systems. Pharmaceutics. 2022;14(9):1840. https:\/\/doi.org\/10.3390\/pharmaceutics14091840.","journal-title":"Pharmaceutics"},{"key":"4848_CR122","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.2147\/IJN.S219670","volume":"14","author":"WQ Li","year":"2019","unstructured":"Li WQ, Wu JY, Xiang DX, Luo SL, Hu XB, Tang TT, Sun TL, Liu XY. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis. Int J Nanomed. 2019;14:8345\u20138360. https:\/\/doi.org\/10.2147\/IJN.S219670","journal-title":"Int J Nanomed"},{"issue":"3","key":"4848_CR123","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/ATVBAHA.115.307057","volume":"36","author":"S Nakashiro","year":"2016","unstructured":"Nakashiro S, Matoba T, Umezu R, Koga J, Tokutome M, Katsuki S, Nakano K, Sunagawa K, Egashira K. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte\/Macrophage Differentiation in ApoE-\/- Mice. Arterioscler Thromb Vasc Biol. 2016;36(3):491\u2013500. https:\/\/doi.org\/10.1161\/ATVBAHA.115.307057.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4848_CR124","doi-asserted-by":"publisher","first-page":"19636","DOI":"10.1038\/s41598-020-76416-4","volume":"10","author":"Z Wu","year":"2020","unstructured":"Wu Z, Chen C, Luo J, Davis JRJ, Zhang B, Tang L, Shi W, Liao D. EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2-shRNA to atherosclerotic macrophage in vitro. Sci Rep. 2020;10(1):19636. . https:\/\/doi.org\/10.1038\/s41598-020-76416-4","journal-title":"Sci Rep"},{"issue":"1","key":"4848_CR125","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11010-025-05418-5","volume":"481","author":"J Prasannan","year":"2026","unstructured":"Prasannan J, Sobha A, Jaleel A, Mohanakumari VVT, Ramachandran S. Rhynchophylline alleviates early atherosclerosis by attenuating oxidized low-density lipoprotein-induced foam cell formation and endothelial dysfunction. Mol Cell Biochem. 2026;481(1):473\u2013491. https:\/\/doi.org\/10.1007\/s11010-025-05418-5","journal-title":"Mol Cell Biochem"},{"key":"4848_CR126","doi-asserted-by":"publisher","first-page":"102152","DOI":"10.1016\/j.mtbio.2025.102152","volume":"34","author":"S Ding","year":"2025","unstructured":"Ding S, Xu W, Liu X, Wu Z, He X, Huang Y, Chen J, Yao W, Zhou H, Yang Y, Pu J. Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis. Mater Today Bio. 2025;34:102152. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102152.","journal-title":"Mater Today Bio"},{"key":"4848_CR127","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.freeradbiomed.2025.03.004","volume":"232","author":"T Li","year":"2025","unstructured":"Li T, Liu X, Yang B, Wang Z, Chen Y, Jin X, Shen C. Selenium-loaded porous silica nanospheres improve cardiac repair after myocardial infarction by enhancing antioxidant activity and mitophagy. Free Radic Biol Med. 2025;232:292\u2013305. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.03.004.","journal-title":"Free Radic Biol Med"},{"key":"4848_CR128","doi-asserted-by":"publisher","first-page":"103427","DOI":"10.1016\/j.redox.2024.103427","volume":"78","author":"YN Lee","year":"2024","unstructured":"Lee YN, Wu YJ, Su CH, Wang BJ, Yang SH, Lee HI, Chou YH, Tien TY, Lin CF, Chan WH, Chung CH, Wang SW, Yeh HI. Fluorescent gold nanoclusters possess multiple actions against atherosclerosis. Redox Biol. 2024;78:103427. https:\/\/doi.org\/10.1016\/j.redox.2024.103427.","journal-title":"Redox Biol"},{"issue":"8","key":"4848_CR129","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.bioactmat.2020.12.030","volume":"6","author":"KN Alagarsamy","year":"2021","unstructured":"Alagarsamy KN, Mathan S, Yan W, Rafieerad A, Sekaran S, Manego H, Dhingra S. Carbon nanomaterials for cardiovascular theranostics: Promises and challenges. Bioact Mater. 2021;6(8):2261\u20132280. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.12.030","journal-title":"Bioact Mater"},{"issue":"4","key":"4848_CR130","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1049\/nbt2.12137","volume":"17","author":"W Li","year":"2023","unstructured":"Li W, Liu C, Wang S, Liu N. Neutrophil membrane biomimetic delivery system (Ptdser-NM-Lipo\/Fer-1) designed for targeting atherosclerosis therapy. IET Nanobiotechnol. 2023;17(4):387\u2013395. https:\/\/doi.org\/10.1049\/nbt2.12137","journal-title":"IET Nanobiotechnol"},{"issue":"4","key":"4848_CR131","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11010-026-05494-1","volume":"481","author":"L Luo","year":"2026","unstructured":"Luo L, Li L, Wu S, Zeng X, Fan L. Mesenchymal stem cell exosomes alleviate ischemic myocardial injury by miR-125b-5p\/BTG2 pathway. Mol Cell Biochem. 2026;481(4):1713\u20131725. https:\/\/doi.org\/10.1007\/s11010-026-05494-1","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"4848_CR132","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.1038\/s41467-025-64201-8","volume":"16","author":"F Fang","year":"2025","unstructured":"Fang F, Wang E, Yang H, Zhao T, Wang Q, Zhang Z, Song Y, Liu X. Reprogramming mitochondrial metabolism and epigenetics of macrophages via miR-10a liposomes for atherosclerosis therapy. Nat Commun. 2025;16(1):9117. https:\/\/doi.org\/10.1038\/s41467-025-64201-8.","journal-title":"Nat Commun"},{"key":"4848_CR133","doi-asserted-by":"publisher","first-page":"122976","DOI":"10.1016\/j.biomaterials.2024.122976","volume":"316","author":"L Tong","year":"2025","unstructured":"Tong L, Wang Q, Zhang Y, Lai F, Xu J, Yin W, Zhang S, Wei G, Yin J, Yi H, Storm G, Wang Z, Huang R, Xu T, Wang JW. Myocardial delivery of miR30d with peptide-functionalized milk-derived extracellular vesicles for targeted treatment of hypertrophic heart failure. Biomaterials. 2025;316:122976. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122976.","journal-title":"Biomaterials"},{"issue":"1","key":"4848_CR134","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12951-025-03690-7","volume":"23","author":"S Wang","year":"2025","unstructured":"Wang S, Lv Y, Wang X, Zhang Z, Li J, Pan TI, Yung MAC, Zhang F, Zhang H, Meng J, Lian H, Wen S, Hao X, Wang P, Zhang Q, He T, Zhang Y, Wang X, Song J, Cui Y. MiR-7683-3p from M2-exosomes attenuated atherosclerosis by activating the PPAR\u03b3-LXR\u03b1-ABCG1 pathway mediated cholesterol efflux of vascular smooth muscle cell derived foam cells. J Nanobiotechnol. 2025;23(1):618. https:\/\/doi.org\/10.1186\/s12951-025-03690-7.","journal-title":"J Nanobiotechnol"},{"key":"4848_CR135","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.nano.2022.102557","volume":"43","author":"G Li","year":"2022","unstructured":"Li G, et al. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis. Nanomedicine. 2022;43:102557. https:\/\/doi.org\/10.1016\/j.nano.2022.102557.","journal-title":"Nanomedicine"},{"key":"4848_CR136","doi-asserted-by":"publisher","first-page":"1147699","DOI":"10.3389\/fmolb.2023.1147699","volume":"10","author":"T Yang","year":"2023","unstructured":"Yang T, et al. Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review. Front Mol Biosci. 2023;10:1147699. https:\/\/doi.org\/10.3389\/fmolb.2023.1147699.","journal-title":"Front Mol Biosci"},{"key":"4848_CR137","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jconrel.2023.06.035","volume":"360","author":"SY Chong","year":"2023","unstructured":"Chong SY, et al. Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability. J Control Release. 2023;360:344\u2013364. https:\/\/doi.org\/10.1016\/j.jconrel.2023.06.035","journal-title":"J Control Release"},{"key":"4848_CR138","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.3390\/ma14226921","volume":"14","author":"X Hu","year":"2021","unstructured":"Hu X, Zhao P, Lu Y, Liu Y. ROS-Based Nanoparticles for Atherosclerosis Treatment. Mater (Basel). 2021;14:6921. https:\/\/doi.org\/10.3390\/ma14226921.","journal-title":"Mater (Basel)"},{"key":"4848_CR139","doi-asserted-by":"publisher","first-page":"122258","DOI":"10.1016\/j.ijpharm.2022.122258","volume":"628","author":"LC du Toit","year":"2022","unstructured":"du Toit LC, Demana H, P., Essop Choonara Y. A nano-enabled biotinylated anti-LDL theranostic system to modulate systemic LDL cholesterol. Int J Pharm. 2022;628:122258. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122258.","journal-title":"Int J Pharm"},{"key":"4848_CR140","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.2147\/IJN.S270229","volume":"15","author":"H Li","year":"2020","unstructured":"Li H, et al. The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics. Int J Nanomed. 2020;15:7199\u20137214. https:\/\/doi.org\/10.2147\/IJN.S270229","journal-title":"Int J Nanomed"},{"key":"4848_CR141","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jconrel.2023.02.036","volume":"356","author":"R Huang","year":"2023","unstructured":"Huang R, et al. Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy. J Control Release. 2023;356:610\u2013622. https:\/\/doi.org\/10.1016\/j.jconrel.2023.02.036","journal-title":"J Control Release"},{"key":"4848_CR142","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40580-019-0214-1","volume":"7","author":"J Chen","year":"2020","unstructured":"Chen J, et al. High density lipoprotein mimicking nanoparticles for atherosclerosis. Nano Converg. 2020;7:6. https:\/\/doi.org\/10.1186\/s40580-019-0214-1.","journal-title":"Nano Converg"},{"key":"4848_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104370","author":"F Pedro","year":"2025","unstructured":"Pedro F, et al. Advancing atherosclerosis treatment: Drug encapsulation nanosystems and synthetic HDL nanoparticles. Drug Discov Today. 2025;30:104370. https:\/\/doi.org\/10.1016\/j.drudis.2025.104370","journal-title":"Drug Discov Today"},{"key":"4848_CR144","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.122.321723","volume":"132","author":"K Cui","year":"2023","unstructured":"Cui K, et al. Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression. Circ Res. 2023;132:e22\u201342. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321723.","journal-title":"Circ Res"},{"issue":"8","key":"4848_CR145","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s11010-023-04821-0","volume":"479","author":"N Wang","year":"2024","unstructured":"Wang N, Chen C, Ren J, Dai D. MicroRNA delivery based on nanoparticles of cardiovascular diseases. Mol Cell Biochem. 2024;479(8):1909\u20131923. https:\/\/doi.org\/10.1007\/s11010-023-04821-0","journal-title":"Mol Cell Biochem"},{"key":"4848_CR146","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1021\/acsomega.3c08428","volume":"9","author":"D Elkhayat","year":"2024","unstructured":"Elkhayat D, Abdelmalak NS, Amer R, Awad HH. Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology, In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats. ACS Omega. 2024;9:8103\u20138116. https:\/\/doi.org\/10.1021\/acsomega.3c08428","journal-title":"ACS Omega"},{"key":"4848_CR147","doi-asserted-by":"publisher","unstructured":"Li H, Zhu J, Xu YW et al. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox Biol. 2022;54:102384. https:\/\/doi.org\/10.1016\/j.redox.2022.102384.","DOI":"10.1016\/j.redox.2022.102384"},{"key":"4848_CR148","doi-asserted-by":"publisher","first-page":"100957","DOI":"10.1016\/j.mtbio.2024.100957","volume":"25","author":"T Yu","year":"2024","unstructured":"Yu T, Xu Q, Chen X, et al. Biomimetic nanomaterials in myocardial infarction treatment: Harnessing bionic strategies for advanced therapeutics. Mater Today Bio. 2024;25:100957. https:\/\/doi.org\/10.1016\/j.mtbio.2024.100957.","journal-title":"Mater Today Bio"},{"issue":"14","key":"4848_CR149","doi-asserted-by":"publisher","first-page":"e2404979","DOI":"10.1002\/adhm.202404979","volume":"14","author":"W Yang","year":"2025","unstructured":"Yang W, Li X, Lei J, et al. Targeted Anti-Inflammatory Nanozymes with Pro-Angiogenic Activity for Myocardial Infarction Therapy. Adv Healthc Mater. 2025;14(14):e2404979. https:\/\/doi.org\/10.1002\/adhm.202404979.","journal-title":"Adv Healthc Mater"},{"key":"4848_CR150","doi-asserted-by":"publisher","unstructured":"Guan Y, Wen J, Niu H, Zhai J, Dang Y, Guan J. Targeted delivery of engineered adipose-derived stem cell secretome to promote cardiac repair after myocardial infarction. J Control Release. 2025;383:113765. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113765.","DOI":"10.1016\/j.jconrel.2025.113765"},{"key":"4848_CR151","doi-asserted-by":"publisher","first-page":"123410","DOI":"10.1016\/j.biomaterials.2025.123410","volume":"322","author":"H Zhang","year":"2025","unstructured":"Zhang H, Jiang H, Xie W, Qian B, Long Q, Qi Z, Huang S, Zhong Y, Zhang Y, Chang L, Zhang J, Zhao Q, Wang X, Ye X. LNPs-mediated VEGF-C mRNA delivery promotes heart repair and attenuates inflammation by stimulating lymphangiogenesis post-myocardial infarction. Biomaterials. 2025;322:123410. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123410.","journal-title":"Biomaterials"},{"key":"4848_CR152","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.jmccpl.2026.100850","volume":"16","author":"RL Harper","year":"2026","unstructured":"Harper RL, Farrugia GE, Krstevski C, Alexander N, Raffaut SR, Harrison T, Thomas A, Kiriazis H, Dogra A, Vidallon MLP, Wang X, Chang H, Donner DG, Lelliott PM, Pinto AR. Spatio-temporal targeting of cardiac cells with lipid nanoparticles after myocardial infarction. J Mol Cell Cardiol plus. 2026;16:100850. https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100850.","journal-title":"J Mol Cell Cardiol plus"},{"issue":"6","key":"4848_CR153","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/17435889.2026.2628309","volume":"21","author":"H Yu","year":"2026","unstructured":"Yu H, Li S, Niu H, Li Z, Gai Y, Sun B, Zhao L. Precise atorvastatin delivery by cardiac homing peptide functionalized nanoliposomes for myocardial damage repair after myocardial infarction. Nanomed (London England). 2026;21(6):789\u2013801. https:\/\/doi.org\/10.1080\/17435889.2026.2628309.","journal-title":"Nanomed (London England)"},{"key":"4848_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-026-10095-0","author":"F Zhao","year":"2026","unstructured":"Zhao F, Liu T, Yu X. Mesenchymal stem cell-originated exosomal ZEB1 alleviates hypoxia\/reperfusion-induced apoptosis, oxidative stress, and endoplasmic reticulum stress in cardiomyocytes via regulating UBIAD1. J Bioenerg Biomembr. 2026;58(1):27.Advance online publication. https:\/\/doi.org\/10.1007\/s10863-026-10095-0","journal-title":"J Bioenerg Biomembr"},{"issue":"4","key":"4848_CR155","doi-asserted-by":"publisher","first-page":"300060526143574","DOI":"10.1177\/03000605261435745","volume":"54","author":"X Liu","year":"2026","unstructured":"Liu X, Ge Y, Xing X, Liu J, Chen H, Wang D, Ni H, Li W, Wang F. Vascular endothelial cell-derived small extracellular vesicles: A protective role against cardiomyocyte apoptosis in ischemia-reperfusion injury through miR410-3p-modulated smad7 pathway. J Int Med Res. 2026;54(4):3000605261435745. https:\/\/doi.org\/10.1177\/03000605261435745.","journal-title":"J Int Med Res"},{"issue":"10","key":"4848_CR156","doi-asserted-by":"publisher","first-page":"e70178","DOI":"10.1002\/jev2.70178","volume":"14","author":"W Wang","year":"2025","unstructured":"Wang W, Han Z, Aafreen S, Zivko C, Gololobova O, Wei Z, Cotin G, Felder-Flesc D, Mahairaki V, Witwer KW, Bulte JWM, Weiss RG, Liu G. Magnetically Labelled iPSC-Derived Extracellular Vesicles Enable MRI\/MPI-Guided Regenerative Therapy for Myocardial Infarction. J Extracell vesicles. 2025;14(10):e70178. https:\/\/doi.org\/10.1002\/jev2.70178.","journal-title":"J Extracell vesicles"},{"issue":"5","key":"4848_CR157","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4149\/gpb_2025022","volume":"44","author":"M Wang","year":"2025","unstructured":"Wang M, Zhao C, Li T, Song T, Hao Y, Cui W, Guan M, Hou Y, Li Y. Hypoxia-conditioned cardiomyocyte-derived exosomes attenuate myocardial injury via ANP-mediated M2 macrophage polarization. Gen Physiol Biophys. 2025;44(5):377\u2013389. https:\/\/doi.org\/10.4149\/gpb_2025022","journal-title":"Gen Physiol Biophys"},{"key":"4848_CR158","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/acsbiomaterials.1c01198","volume":"8","author":"G Zhou","year":"2022","unstructured":"Zhou G, Hu T, Du Q, Huang W, Yao C. Nanoparticle-Delivered microRNA-153-3p Alleviates Myocardial Infarction-Induced Myocardial Injury in a Rat Model. ACS Biomater Sci Eng. 2022;8:1696\u20131705. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c01198","journal-title":"ACS Biomater Sci Eng"},{"key":"4848_CR159","doi-asserted-by":"publisher","first-page":"7847142","DOI":"10.1155\/2019\/7847142","volume":"2019","author":"PM Boarescu","year":"2019","unstructured":"Boarescu PM, et al. Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction. Oxid Med Cell Longev. 2019;2019:7847142. https:\/\/doi.org\/10.1155\/2019\/7847142.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4848_CR160","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1038\/s41467-024-49901-x","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liu S, Liang Y, He Y, Li Q, Zhan J, Hou H, Qiu X. Single dose of intravenous miR199a-5p delivery targeting ischemic heart for long-term repair of myocardial infarction. Nat Commun. 2024;15(1):5565. https:\/\/doi.org\/10.1038\/s41467-024-49901-x.","journal-title":"Nat Commun"},{"issue":"1","key":"4848_CR161","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12951-026-04146-2","volume":"24","author":"M Li","year":"2026","unstructured":"Li M, Zhao B, Liu J. Endogenous and exogenous stimuli-driven intelligent nanocarriers: emerging strategies for the treatment of myocardial infarction. J Nanobiotechnol. 2026;24(1):249. https:\/\/doi.org\/10.1186\/s12951-026-04146-2.","journal-title":"J Nanobiotechnol"},{"issue":"21","key":"4848_CR162","doi-asserted-by":"publisher","first-page":"e2308910","DOI":"10.1002\/advs.202308910","volume":"11","author":"D Hu","year":"2024","unstructured":"Hu D, Li R, Li Y, Wang M, Wang L, Wang S, Cheng H, Zhang Q, Fu C, Qian Z, Wei Q. Inflammation-Targeted Nanomedicines Alleviate Oxidative Stress and Reprogram Macrophages Polarization for Myocardial Infarction Treatment. Adv Sci (Weinh). 2024;11(21):e2308910. https:\/\/doi.org\/10.1002\/advs.202308910.","journal-title":"Adv Sci (Weinh)"},{"key":"4848_CR163","doi-asserted-by":"publisher","first-page":"103024","DOI":"10.1016\/j.mtbio.2026.103024","volume":"37","author":"N Xu","year":"2026","unstructured":"Xu N, Chi Z, Zhang H, Wu J, Sun R, Tian C. Corrigendum to \u2018CD11b-modified ROS\/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment\u2019 [Mater. Today Bio 34, October 2025, 102226]. Mater today Bio. 2026;37:103024. https:\/\/doi.org\/10.1016\/j.mtbio.2026.103024.","journal-title":"Mater today Bio"},{"issue":"7","key":"4848_CR164","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1021\/acsnano.5c17071","volume":"20","author":"H Ling","year":"2026","unstructured":"Ling H, Liu A, Zhang Y, Lin Q, Song C. Biomimetic Selenium-Encrusted Prussian Blue Nanozyme for Myocardial Infarction by Coordinated Enhancement of Mitophagy and Reactive Oxygen Species Scavenging. ACS Nano. 2026;20(7):5687\u20135707. https:\/\/doi.org\/10.1021\/acsnano.5c17071","journal-title":"ACS Nano"},{"issue":"14","key":"4848_CR165","doi-asserted-by":"publisher","first-page":"e05502","DOI":"10.1002\/adhm.202505502","volume":"15","author":"K Feng","year":"2026","unstructured":"Feng K, An J, Zhang X, Li G, Ruan Y, Huang H, Sun Y, Liu X, Sun X. One Stone, Four Birds: Multiple Modulation of Infarct Microenvironment-Based ROS-Responsive Hydrogel for Cardiac Repair. Adv Healthc Mater. 2026;15(14):e05502. https:\/\/doi.org\/10.1002\/adhm.202505502.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"4848_CR166","doi-asserted-by":"publisher","first-page":"e04876","DOI":"10.1002\/adhm.202504876","volume":"15","author":"Y Yang","year":"2026","unstructured":"Yang Y, Shen J, Huang K, Wang H, Jia Y, Zhang X, Jiao Y, Weng X, Zhang H, Fu Z. Bioinspired Spatiotemporal-Responsive Nanoparticles Synergistically Regulate Mitochondrial Repair and Inhibit Fibrosis in Acute Myocardial Infarction Treatment. Adv Healthc Mater. 2026;15(12):e04876. https:\/\/doi.org\/10.1002\/adhm.202504876.","journal-title":"Adv Healthc Mater"},{"key":"4848_CR167","doi-asserted-by":"publisher","first-page":"13499","DOI":"10.2147\/IJN.S546817","volume":"20","author":"L Wang","year":"2025","unstructured":"Wang L, Wang K, Zheng H. Macrophage Membrane-Coated Nanocarriers in Myocardial Infarction: A Paradigm Shift in Targeted Cardiac Therapy. Int J Nanomed. 2025;20:13499\u201313525. https:\/\/doi.org\/10.2147\/IJN.S546817","journal-title":"Int J Nanomed"},{"key":"4848_CR168","doi-asserted-by":"publisher","first-page":"122890","DOI":"10.1016\/j.biomaterials.2024.122890","volume":"314","author":"K Wang","year":"2025","unstructured":"Wang K, Sun Y, Zhu K, Liu Y, Zheng X, Yang Z, Man F, Huang L, Zhu Z, Huang Q, Li Y, Dong H, Zhao J, Li Y. Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery. Biomaterials. 2025;314:122890. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122890.","journal-title":"Biomaterials"},{"key":"4848_CR169","doi-asserted-by":"publisher","first-page":"114816","DOI":"10.1016\/j.ejpb.2025.114816","volume":"214","author":"NH Kamal","year":"2025","unstructured":"Kamal NH, Heikal LA, Bakr BA, Helmy MW, Abdallah OY. HDL and LDL-bioinspired nanocarriers in acellular targeted delivery of Icariin for cardiac repair post myocardial infarction. Eur J Pharm Biopharm. 2025;214:114816. https:\/\/doi.org\/10.1016\/j.ejpb.2025.114816.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"4848_CR170","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1021\/acsnano.5c17217","volume":"20","author":"C Liu","year":"2026","unstructured":"Liu C, Xie W, Cao Z, Lv Y, Fu X. Fusogenic Hybrid Gelled Nanovesicles Combining Mesenchymal Stromal Cell Cargo with Cholesterol-Modified Macrophage Membranes for Targeted Myocardial Infarction Therapy. ACS Nano. 2026;20(7):5720\u20135737. https:\/\/doi.org\/10.1021\/acsnano.5c17217","journal-title":"ACS Nano"},{"key":"4848_CR171","doi-asserted-by":"publisher","first-page":"119055","DOI":"10.1016\/j.biopha.2026.119055","volume":"195","author":"N Li","year":"2026","unstructured":"Li N, Zhao Y, Jiang X, Ran D, Wang Y, Zheng L, Wang Z. Liposomes and macrophage membrane co-assembled biomimetic nanoparticles alleviate cardiac insufficiency after myocardial infarction. Biomed pharmacotherapy = Biomedecine pharmacotherapie. 2026;195:119055. https:\/\/doi.org\/10.1016\/j.biopha.2026.119055.","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"4848_CR172","doi-asserted-by":"publisher","first-page":"114647","DOI":"10.1016\/j.jconrel.2026.114647","volume":"391","author":"P Wang","year":"2026","unstructured":"Wang P, Li R, Ni J, Li D, Ting MH, Ma K, Fu G, Ge J, Zhao S, Zhang W, Zhang N, Liu X. Dual-biomimetic Nanodecoys reprogram cardiac macrophages by suppressing STING signaling for heart repair. J controlled release: official J Controlled Release Soc. 2026;391:114647. https:\/\/doi.org\/10.1016\/j.jconrel.2026.114647.","journal-title":"J controlled release: official J Controlled Release Soc"},{"key":"4848_CR173","doi-asserted-by":"publisher","first-page":"102631","DOI":"10.1016\/j.mtbio.2025.102631","volume":"36","author":"J Shen","year":"2025","unstructured":"Shen J, Fan Z, Ren L, Cheng Y, Wu C. Interferon-stimulated gene 15 small interfering RNA-loaded polarized mesoporous silica nanocarriers remodel the immune microenvironment to ameliorate post-myocardial infarction heart failure. Mater today Bio. 2025;36:102631. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102631.","journal-title":"Mater today Bio"},{"key":"4848_CR174","doi-asserted-by":"publisher","unstructured":"Zhang K, Tao H, Zhu D, Yue Z, Hu S, Wu Y, Yan N, Hu Y, Liu S, Liu M, Vahl TP, Ranard LS, Cheng X, Romanov A, Liu J, Zhang SW, Li Y, Lu C, Shen M, Lewis A, Cheng K. Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction.Science. 2026;391(6789):edau9394. https:\/\/doi.org\/10.1126\/science.adu9394","DOI":"10.1126\/science.adu9394"},{"issue":"1","key":"4848_CR175","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12951-026-04431-0","volume":"24","author":"C Chen","year":"2026","unstructured":"Chen C, Lu W, Pan Q, Cui C, Zhang Y, Wang H, Han J, Yuan S, Lin Z, Xie Y, Dou K, Hou J. Antibody-conjugated SIS3-loaded PLGA@polydopamine nanoparticles alleviate cardiac fibrosis by modulating Smad3 signaling in myofibroblasts. J Nanobiotechnol. 2026;24(1):523. https:\/\/doi.org\/10.1186\/s12951-026-04431-0.","journal-title":"J Nanobiotechnol"},{"key":"4848_CR176","doi-asserted-by":"publisher","first-page":"e110621194025","DOI":"10.2174\/1573403X17666210611115823","volume":"18","author":"N Moradifar","year":"2022","unstructured":"Moradifar N, Kiani AA, Veiskaramian A, Karami K. Role of Organic and Inorganic Nanoparticles in the Drug Delivery System for Hypertension Treatment: A Systematic Review. Curr Cardiol Rev. 2022;18:e110621194025. https:\/\/doi.org\/10.2174\/1573403X17666210611115823.","journal-title":"Curr Cardiol Rev"},{"key":"4848_CR177","doi-asserted-by":"publisher","first-page":"999404","DOI":"10.3389\/fphar.2022.999404","volume":"13","author":"F Yang","year":"2022","unstructured":"Yang F, Xue J, Wang G, Diao Q. Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Front Pharmacol. 2022;13:999404. https:\/\/doi.org\/10.3389\/fphar.2022.999404.","journal-title":"Front Pharmacol"},{"key":"4848_CR178","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijpharm.2011.10.012","volume":"422","author":"M Beck-Broichsitter","year":"2012","unstructured":"Beck-Broichsitter M, et al. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. Int J Pharm. 2012;422:398\u2013408. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.012.","journal-title":"Int J Pharm"},{"key":"4848_CR179","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2217\/nnm-2017-0130","volume":"12","author":"X Guo","year":"2017","unstructured":"Guo X, Zhu X, Gao J, Liu D, Dong C, Jin X. PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma. Nanomed (Lond). 2017;12:2611\u20132624. https:\/\/doi.org\/10.2217\/nnm-2017-0130","journal-title":"Nanomed (Lond)"},{"key":"4848_CR180","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.addr.2012.01.020","volume":"64","author":"E Fleige","year":"2012","unstructured":"Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev. 2012;64:866\u2013884. https:\/\/doi.org\/10.1016\/j.addr.2012.01.020","journal-title":"Adv Drug Deliv Rev"},{"key":"4848_CR181","doi-asserted-by":"publisher","first-page":"e16951","DOI":"10.1016\/j.heliyon.2023.e16951","volume":"9","author":"SD Hettiarachchi","year":"2023","unstructured":"Hettiarachchi SD, Kwon YM, Omidi Y, Speth RC. Nanoparticle approaches for the renin-angiotensin system. Heliyon. 2023;9:e16951. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16951.","journal-title":"Heliyon"},{"key":"4848_CR182","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/ijms25020846","volume":"25","author":"A Barta","year":"2024","unstructured":"Barta A, Cebova M, Kovac A, Koneracka M, Zavisova V, Pechanova O. Aliskiren-Loaded Nanoparticles Downregulate (Pro)renin Receptor and ACE Gene Expression in the Heart of Spontaneously Hypertensive Rats: Effect on NADPH Oxidase. Int J Mol Sci. 2024;25:846. https:\/\/doi.org\/10.3390\/ijms25020846.","journal-title":"Int J Mol Sci"},{"key":"4848_CR183","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s13346-024-01532-x","volume":"14","author":"S Abedin","year":"2024","unstructured":"Abedin S, Adeleke OA. State of the art in pediatric nanomedicines. Drug Deliv Transl Res. 2024;14:2299\u20132324. https:\/\/doi.org\/10.1007\/s13346-024-01532-x","journal-title":"Drug Deliv Transl Res"},{"key":"4848_CR184","doi-asserted-by":"publisher","first-page":"113000","DOI":"10.1016\/j.intimp.2024.113000","volume":"141","author":"AY Kira","year":"2024","unstructured":"Kira AY, et al. Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NF\u03baB\/NLRP3\/IL-1\u03b2 signaling in rats: Unraveling new roles beyond calcium channel blocking. Int Immunopharmacol. 2024;141:113000. https:\/\/doi.org\/10.1016\/j.intimp.2024.113000.","journal-title":"Int Immunopharmacol"},{"key":"4848_CR185","doi-asserted-by":"publisher","unstructured":"Zhao P et al. Advances in biomimetic nano delivery systems for pulmonary hypertension therapy. Acta Biomater. 2026;211:266\u2013287. https:\/\/doi.org\/10.1016\/j.actbio.2025.08.034","DOI":"10.1016\/j.actbio.2025.08.034"},{"key":"4848_CR186","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/pharmaceutics13081170","volume":"13","author":"RG Geetha","year":"2021","unstructured":"Geetha RG, Ramachandran S. Recent Advances in the Anti-Inflammatory Activity of Plant-Derived Alkaloid Rhynchophylline in Neurological and Cardiovascular Diseases. Pharmaceutics. 2021;13:1170. https:\/\/doi.org\/10.3390\/pharmaceutics13081170.","journal-title":"Pharmaceutics"},{"key":"4848_CR187","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/pharmaceutics14050895","volume":"14","author":"S Baher","year":"2022","unstructured":"Baher S, Yaqoubi S, Asare-Addo K, Hamishehkar H, Nokhodchi A. Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension. Pharmaceutics. 2022;14:895. https:\/\/doi.org\/10.3390\/pharmaceutics14050895.","journal-title":"Pharmaceutics"},{"key":"4848_CR188","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/FJC.0000000000001497","volume":"83","author":"E Jafree","year":"2024","unstructured":"Jafree E, et al. Interleukin-1 Inhibition for the Prevention and Treatment of Heart Failure. J Cardiovasc Pharmacol. 2024;83:522\u2013530. https:\/\/doi.org\/10.1097\/FJC.0000000000001497","journal-title":"J Cardiovasc Pharmacol"},{"key":"4848_CR189","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ejhf.942","volume":"19","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure. Eur J Heart Fail. 2017;19:1379\u20131389. https:\/\/doi.org\/10.1002\/ejhf.942","journal-title":"Eur J Heart Fail"},{"key":"4848_CR190","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ejhf.873","volume":"19","author":"L Bosch","year":"2017","unstructured":"Bosch L, Jaufeerally F, Leong KTG, Ong HY, Ng TP, Richards AM, Arslan F, Ling LH, et al. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Eur J Heart Fail. 2017;19:1664\u20131671. https:\/\/doi.org\/10.1002\/ejhf.873","journal-title":"Eur J Heart Fail"},{"key":"4848_CR191","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/nn5061404","volume":"9","author":"N Hardy","year":"2015","unstructured":"Hardy N, et al. Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-Type Ca2\u2009+\u2009channel enables simultaneous reduction of cardiac ischemia-reperfusion injury. ACS Nano. 2015;9:279\u2013289. https:\/\/doi.org\/10.1021\/nn5061404","journal-title":"ACS Nano"},{"key":"4848_CR192","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.2174\/1381612821666150803151758","volume":"21","author":"AK Jain","year":"2015","unstructured":"Jain AK, Mehra NK, Swarnakar NK. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des. 2015;21:4441\u20134455. https:\/\/doi.org\/10.2174\/1381612821666150803151758","journal-title":"Curr Pharm Des"},{"key":"4848_CR193","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.nano.2018.12.014","volume":"16","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, et al. Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy. Nanomedicine. 2019;16:236\u2013249. https:\/\/doi.org\/10.1016\/j.nano.2018.12.014","journal-title":"Nanomedicine"},{"key":"4848_CR194","doi-asserted-by":"publisher","first-page":"13925","DOI":"10.2147\/IJN.S497590","volume":"19","author":"Z Ci","year":"2024","unstructured":"Ci Z, et al. Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation. Int J Nanomed. 2024;19:13925\u201313946. https:\/\/doi.org\/10.2147\/IJN.S497590","journal-title":"Int J Nanomed"},{"key":"4848_CR195","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1039\/d0nh00267d","volume":"5","author":"Y Liao","year":"2020","unstructured":"Liao Y, Zhang Y, Blum NT, Lin J, Huang P. Biomimetic hybrid membrane-based nanoplatforms: synthesis, properties and biomedical applications. Nanoscale Horiz. 2020;5:1293\u20131302. https:\/\/doi.org\/10.1039\/d0nh00267d","journal-title":"Nanoscale Horiz"},{"key":"4848_CR196","doi-asserted-by":"publisher","first-page":"135793","DOI":"10.1016\/j.ijbiomac.2024.135793","volume":"280","author":"P Liao","year":"2024","unstructured":"Liao P, et al. Specific peptides targeting the myocardiocyte are prognostic markers for heart attack: Function of \u03b1-SMA protein. Int J Biol Macromol. 2024;280:135793. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135793.","journal-title":"Int J Biol Macromol"},{"issue":"19","key":"4848_CR197","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.7150\/thno.100388","volume":"14","author":"T Aili","year":"2024","unstructured":"Aili T, Zong JB, Zhou YF, Liu YX, Yang XL, Hu B, Wu JH. Recent advances of self-assembled nanoparticles in the diagnosis and treatment of atherosclerosis. Theranostics. 2024;14(19):7505\u20137533. https:\/\/doi.org\/10.7150\/thno.100388","journal-title":"Theranostics"},{"key":"4848_CR198","doi-asserted-by":"publisher","first-page":"1342832","DOI":"10.3389\/fcvm.2024.1342832","volume":"11","author":"LL Marinho","year":"2024","unstructured":"Marinho LL, et al. Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study. Front Cardiovasc Med. 2024;11:1342832. https:\/\/doi.org\/10.3389\/fcvm.2024.1342832.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4848_CR199","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12951-024-02529-x","volume":"22","author":"J Zhen","year":"2024","unstructured":"Zhen J, Li X, Yu H, Du B. High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review. J Nanobiotechnol. 2024;22(1):263. https:\/\/doi.org\/10.1186\/s12951-024-02529-x.","journal-title":"J Nanobiotechnol"},{"issue":"824","key":"4848_CR200","doi-asserted-by":"publisher","first-page":"eadg9256","DOI":"10.1126\/scisignal.adg9256","volume":"17","author":"YC Lin","year":"2024","unstructured":"Lin YC, Swendeman S, Moreira IS, Ghosh A, Kuo A, Ros\u00e1rio-Ferreira N, Guo S, Culbertson A, Levesque MV, Cartier A, Seno T, Schmaier A, Galvani S, Inoue A, Parikh SM, FitzGerald GA, Zurakowski D, Liao M, Flaumenhaft R, G\u00fcm\u00fc\u015f ZH, Hla T. Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation. Sci Signal. 2024;17(824):eadg9256. https:\/\/doi.org\/10.1126\/scisignal.adg9256.","journal-title":"Sci Signal"},{"issue":"4","key":"4848_CR201","doi-asserted-by":"publisher","first-page":"111335","DOI":"10.1016\/j.jbc.2026.111335","volume":"302","author":"TF Dorweiler","year":"2026","unstructured":"Dorweiler TF, Hla T, Apolipoprotein M. Structural insights, functional roles, and therapeutic approaches in vascular disease. J Biol Chem. 2026;302(4):111335. https:\/\/doi.org\/10.1016\/j.jbc.2026.111335.","journal-title":"J Biol Chem"},{"key":"4848_CR202","doi-asserted-by":"publisher","unstructured":"Zhao Y, Xie R, Yodsanit N, Ye M, Wang Y, Gong S. Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy. Nano Today. 2020;35:100986. https:\/\/doi.org\/10.1016\/j.nantod.2020.100986","DOI":"10.1016\/j.nantod.2020.100986"},{"key":"4848_CR203","doi-asserted-by":"publisher","first-page":"131742","DOI":"10.1016\/j.ijbiomac.2024.131742","volume":"268","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy. Int J Biol Macromol. 2024;268:131742. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131742.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"4848_CR204","doi-asserted-by":"publisher","first-page":"8999","DOI":"10.1021\/acsami.2c20750","volume":"15","author":"C Jeon","year":"2023","unstructured":"Jeon C, Jun H, Kim S, et al. Clot-Targeted Antithrombotic Liposomal Nanomedicine Containing High Content of H2O2-Activatable Hybrid Prodrugs. ACS Appl Mater Interfaces. 2023;15(7):8999\u20139009. . https:\/\/doi.org\/10.1021\/acsami.2c20750","journal-title":"ACS Appl Mater Interfaces"},{"key":"4848_CR205","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.xphs.2022.01.001","volume":"111","author":"R Shabbir","year":"2022","unstructured":"Shabbir R, et al. Nanoparticles as a Novel Tool to Inhibit Inflammatory Cytokines in Human Lymphocytes and Macrophages of Coronary Artery Disease. J Pharm Sci. 2022;111:1509\u20131521. https:\/\/doi.org\/10.1016\/j.xphs.2022.01.001","journal-title":"J Pharm Sci"},{"issue":"5","key":"4848_CR206","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","volume":"98","author":"K Jomova","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024;98(5):1323\u20131367. https:\/\/doi.org\/10.1007\/s00204-024-03696-4","journal-title":"Arch Toxicol"},{"key":"4848_CR207","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/jbm.a.36723","volume":"107","author":"D He","year":"2019","unstructured":"He D, et al. An injectable scaffold based on temperature-responsive hydrogel and factor-loaded nanoparticles for application in vascularization in tissue engineering. J Biomed Mater Res A. 2019;107:2123\u20132134. https:\/\/doi.org\/10.1002\/jbm.a.36723","journal-title":"J Biomed Mater Res A"},{"issue":"5","key":"4848_CR208","first-page":"7497","volume":"8","author":"M Gao","year":"2015","unstructured":"Gao M, Tang H, Zheng X, Zhou F, Lu W. Association analysis of GWAS and candidate gene loci in a Chinese population with coronary heart disease. Int J Clin Exp Med. 2015;8(5):7497\u20137506.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"4848_CR209","doi-asserted-by":"publisher","first-page":"e004470","DOI":"10.1161\/CIRCGEN.123.004470","volume":"17","author":"A Sherafati","year":"2024","unstructured":"Sherafati A, Norland K, Naderian M, Schaid DJ, Kullo IJ. Polygenic Risk and Coronary Artery Disease Severity. Circ Genom Precis Med. 2024;17(5):e004470. https:\/\/doi.org\/10.1161\/CIRCGEN.123.004470.","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"4848_CR210","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ihj.2017.02.007","volume":"69","author":"P Ambesh","year":"2017","unstructured":"Ambesh P, Campia U, Obiagwu C, Bansal R, Shetty V, Hollander G, Shani J. Nanomedicine in coronary artery disease. Indian Heart J. 2017;69(2):244\u2013251 https:\/\/doi.org\/10.1016\/j.ihj.2017.02.007","journal-title":"Indian Heart J"},{"issue":"17","key":"4848_CR211","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1093\/eurheartj\/ehae883","volume":"46","author":"Y You","year":"2025","unstructured":"You Y, Tian Y, Guo R, Shi J, Kwak KJ, Tong Y, Estania AP, Hsu WH, Liu Y, Hu S, Cao J, Yang L, Bai R, Huang P, Lee LJ, Jiang W, Kim BYS, Ma S, Liu X, Shen Z, Lan F, Phuong Nguyen PK, Lee AS. Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity. Eur Heart J. 2025;46(17):1662\u20131676. https:\/\/doi.org\/10.1093\/eurheartj\/ehae883","journal-title":"Eur Heart J"},{"issue":"12","key":"4848_CR212","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.cpcardiol.2024.102863","volume":"49","author":"S Saravanan","year":"2024","unstructured":"Saravanan S, Palaniappan NA, Panneerselvam A, Palaniyandi T, Rajinikanth S, Shanmugam R, Wahab MRA. Emerging therapeutic and diagnostic strategies for coronary artery disease: Current trends and future perspectives. Curr Probl Cardiol. 2024;49(12):102863. https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102863.","journal-title":"Curr Probl Cardiol"},{"issue":"37","key":"4848_CR213","doi-asserted-by":"publisher","first-page":"49660","DOI":"10.1021\/acsami.4c11370","volume":"16","author":"N Mou","year":"2024","unstructured":"Mou N, Duan X, Qu K, et al. Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis. ACS Appl Mater Interfaces. 2024;16(37):49660\u201349672. https:\/\/doi.org\/10.1021\/acsami.4c11370","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"4848_CR214","doi-asserted-by":"publisher","first-page":"e32073","DOI":"10.1016\/j.heliyon.2024.e32073","volume":"10","author":"B Yang","year":"2024","unstructured":"Yang B, Hang S, Xu S, et al. Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment. Heliyon. 2024;10(11):e32073. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32073.","journal-title":"Heliyon"},{"issue":"8","key":"4848_CR215","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/pharmaceutics17081028","volume":"17","author":"P Karakasis","year":"2025","unstructured":"Karakasis P, Theofilis P, Vlachakis PK, et al. Reprogramming Atherosclerosis: Precision Drug Delivery, Nanomedicine, and Immune-Targeted Therapies for Cardiovascular Risk Reduction. Pharmaceutics. 2025;17(8):1028. https:\/\/doi.org\/10.3390\/pharmaceutics17081028","journal-title":"Pharmaceutics"},{"issue":"553","key":"4848_CR216","doi-asserted-by":"publisher","first-page":"eaay1063","DOI":"10.1126\/scitranslmed.aay1063","volume":"12","author":"W Tao Jr","year":"2020","unstructured":"Tao W, Yurdagul A Jr, Kong N, et al siRNA nanoparticles targeting CaMKII\u03b3 in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med. 2020;12(553):eaay1063. https:\/\/doi.org\/10.1126\/scitranslmed.aay1063.","journal-title":"Sci Transl Med"},{"key":"4848_CR217","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.bioactmat.2026.02.041","volume":"61","author":"H Li","year":"2026","unstructured":"Li H, Qin Y, Zhang J, et al. A foam cell-targeted lipophagy restoration strategy stabilizes vulnerable atherosclerotic plaques. Bioact Mater. 2026;61:879\u2013899. https:\/\/doi.org\/10.1016\/j.bioactmat.2026.02.041","journal-title":"Bioact Mater"},{"issue":"22","key":"4848_CR218","doi-asserted-by":"publisher","first-page":"7134","DOI":"10.1039\/d5na00497g","volume":"7","author":"Y Lin","year":"2025","unstructured":"Lin Y, Huang C, Hou X, Kah JCY, Wang JW. Polydopamine and hyaluronic acid-coated dual-responsive silica nanoparticles for targeted atherosclerosis imaging and therapy. Nanoscale Adv. 2025;7(22):7134\u20137144. https:\/\/doi.org\/10.1039\/d5na00497g","journal-title":"Nanoscale Adv"},{"issue":"1","key":"4848_CR219","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/09592989251375811","volume":"37","author":"J Chen","year":"2026","unstructured":"Chen J, Miao Q, Xiao X. Targeted nanocarriers effectively remove cholesterol from macrophages. Biomed Mater Eng. 2026;37(1):50\u201361. https:\/\/doi.org\/10.1177\/09592989251375811.","journal-title":"Biomed Mater Eng"},{"issue":"5","key":"4848_CR220","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/ijms23052522","volume":"23","author":"B Todaro","year":"2022","unstructured":"Todaro B, Moscardini A, Luin S, Pioglitazone-Loaded PLGA. Nanoparticles Towards the Most Reliable Synthesis Method. Int J Mol Sci. 2022;23(5):2522. https:\/\/doi.org\/10.3390\/ijms23052522","journal-title":"Int J Mol Sci"},{"key":"4848_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.01.024","author":"Z Xu","year":"2023","unstructured":"Xu Z, Wu Z, Huang S, et al. A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment. J Control Release. 2023;354:615-625. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.024","journal-title":"J Control Release"},{"issue":"16","key":"4848_CR222","doi-asserted-by":"publisher","first-page":"e2208989","DOI":"10.1002\/adma.202208989","volume":"35","author":"GB Im","year":"2023","unstructured":"Im GB, Kim YG, Yoo TY, et al. Ceria Nanoparticles as Copper Chaperones that Activate SOD1 for Synergistic Antioxidant Therapy to Treat Ischemic Vascular Diseases. Adv Mater. 2023;35(16):e2208989. https:\/\/doi.org\/10.1002\/adma.202208989.","journal-title":"Adv Mater"},{"issue":"3","key":"4848_CR223","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Adv Pharm Bull. 2023;13(3):446. https:\/\/doi.org\/10.34172\/apb.2023.056","journal-title":"Adv Pharm Bull"},{"key":"4848_CR224","doi-asserted-by":"publisher","unstructured":"Elsaygh J, Zaher A, Parikh MA, Frishman WH, Peterson SJ. Nanotechnology: The Future for Diagnostic and Therapeutic Intervention in Cardiovascular Diseases is Here. Cardiol Rev Published online May 30,2024. https:\/\/doi.org\/10.1097\/CRD.0000000000000727","DOI":"10.1097\/CRD.0000000000000727"},{"key":"4848_CR225","doi-asserted-by":"publisher","unstructured":"Dudhipala N, Ettireddy S, Youssef AAA, et al. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and. Vitro Charact Molecules. 2021;26(24). https:\/\/doi.org\/10.3390\/molecules26247538.","DOI":"10.3390\/molecules26247538"},{"issue":"1","key":"4848_CR226","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/ntno.78102","volume":"7","author":"N Dudhipala","year":"2023","unstructured":"Dudhipala N, Ettireddy S, Youssef AAA, et al Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Preparation. Nanotheranostics. 2023;7(1):117. https:\/\/doi.org\/10.7150\/ntno.78102.","journal-title":"Nanotheranostics"},{"key":"4848_CR227","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2495848","author":"P Salve","year":"2025","unstructured":"Salve P, Khurpe S, Shirke PS, Gawas N, et al. QbD-Employed Formulation and Characterization of Sacubitril-Loaded Solid Lipid Nanoparticles: A Step Forward in Nanotechnology-Based Delivery for Hypertension. Drug Dev Ind Pharm. 2025. https:\/\/doi.org\/10.1080\/03639045.2025.2495848.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"4848_CR228","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13346-021-00958-x","volume":"12","author":"T Alam","year":"2022","unstructured":"Alam T, Ansari MA, Baboota S, Ali J. Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. Drug Deliv Transl Res. 2022;12(3):577\u2013588. https:\/\/doi.org\/10.1007\/s13346-021-00958-x","journal-title":"Drug Deliv Transl Res"},{"key":"4848_CR229","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bioactmat.2021.06.006","volume":"7","author":"T Zhao","year":"2022","unstructured":"Zhao T, Wu W, Sui L, et al. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater. 2022;7:47\u201372. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.06.006.","journal-title":"Bioact Mater"},{"issue":"32","key":"4848_CR230","doi-asserted-by":"publisher","first-page":"e2101207","DOI":"10.1002\/smll.202101207","volume":"17","author":"SP Kwon","year":"2021","unstructured":"Kwon SP, Hwang BH, Park EH, et al. Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction. Small. 2021;17(32):e2101207. https:\/\/doi.org\/10.1002\/smll.202101207.","journal-title":"Small"},{"issue":"7","key":"4848_CR231","doi-asserted-by":"publisher","first-page":"e25126","DOI":"10.1002\/anie.202525126","volume":"65","author":"Z Qu","year":"2026","unstructured":"Qu Z, Meke FN, Zhang Z, et al. Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity. Angew Chem Int Ed Engl. 2026;65(7):e25126. https:\/\/doi.org\/10.1002\/anie.202525126.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4848_CR232","doi-asserted-by":"publisher","first-page":"15515","DOI":"10.2147\/IJN.S544064","volume":"20","author":"NR Abdol Wahab","year":"2025","unstructured":"Abdol Wahab NR, Meor Mohd Affandi MMR, Fakurazi S, Alias E, Hassan H. Engineering Optimized Nanostructured Lipid Carriers for Astaxanthin: A Response Surface Methodology Approach. Int J Nanomed. 2025;20:15515\u201315529. https:\/\/doi.org\/10.2147\/IJN.S544064","journal-title":"Int J Nanomed"},{"issue":"3","key":"4848_CR233","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/ph18030417","volume":"18","author":"N Altuwaijri","year":"2025","unstructured":"Altuwaijri N, Fitaihi R, Alkathiri FA, Bukhari SI, Altalal AM, Alsalhi A, Alsulaiman L, Alomran AO, Aldosari NS, Alqhafi SA, Alhamdan M, Alfaraj R. Assessing the Antibacterial Potential and Biofilm Inhibition Capability of Atorvastatin-Loaded Nanostructured Lipid Carriers via Crystal Violet Assay. Pharmaceuticals (Basel). 2025;18(3):417. https:\/\/doi.org\/10.3390\/ph18030417.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"15","key":"4848_CR234","doi-asserted-by":"publisher","first-page":"e2100787","DOI":"10.1002\/advs.202100787","volume":"8","author":"H Tan","year":"2021","unstructured":"Tan H, Song Y, Chen J, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8(15):e2100787. https:\/\/doi.org\/10.1002\/advs.202100787.","journal-title":"Adv Sci (Weinh)"},{"key":"4848_CR235","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.2147\/IJN.S533628","volume":"20","author":"Q Pan","year":"2025","unstructured":"Pan Q, Chen G, Zhuang X, Li F, Yang Y. Cardiac Homing Peptide-Functionalized Polymeric Nanoparticles Suppressing SHP1 Alleviate Acute Myocardial Infarction Injury by Promoting Efferocytosis and Inhibiting Inflammation. Int J Nanomed. 2025;20:4531\u20134550. https:\/\/doi.org\/10.2147\/IJN.S533628","journal-title":"Int J Nanomed"},{"key":"4848_CR236","doi-asserted-by":"publisher","unstructured":"Dai JQL, Lu Y, Li M. Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms Front Endocrinol (Lausanne). 2024;15:1366285. https:\/\/doi.org\/10.3389\/fendo.2024.1366285","DOI":"10.3389\/fendo.2024.1366285"},{"key":"4848_CR237","doi-asserted-by":"publisher","unstructured":"Xuan X, Zhang J, Fan J,Zhang S. Research progress of Traditional Chinese Medicine (TCM) in targeting inflammation and lipid metabolism disorder for arteriosclerosis intervention: A review Medicine (Baltimore). 2023;102(18):e33748. https:\/\/doi.org\/10.1097\/MD.0000000000033748","DOI":"10.1097\/MD.0000000000033748"},{"key":"4848_CR238","doi-asserted-by":"publisher","first-page":"e151428","DOI":"10.5812\/ijpr-151428","volume":"23","author":"M Shamsi","year":"2024","unstructured":"Shamsi M, et al. Dual Modulation of Canonical and Non-canonical TGF-\u03b2\/ROS\/Erk1\/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin Loaded in Solid Lipid Nanoparticles and Curcumin in Atherosclerosis Therapy. Iran J Pharm Res. 2024;23:e151428. https:\/\/doi.org\/10.5812\/ijpr-151428.","journal-title":"Iran J Pharm Res"},{"key":"4848_CR239","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.2147\/IJN.S295508","volume":"16","author":"M Hesari","year":"2021","unstructured":"Hesari M, et al. Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases. Int J Nanomed. 2021;16:3293\u20133315. https:\/\/doi.org\/10.2147\/IJN.S295508","journal-title":"Int J Nanomed"},{"key":"4848_CR240","doi-asserted-by":"publisher","unstructured":"ND, ZQ, AGHJ, LH, LJ. An Up-to-Date Review of Traditional Chinese Medicine in the Treatment of Atherosclerosis: Components, Mechanisms, and Therapeutic Potentials. Phytother Res. 2025;39(8):3709\u20133735. https:\/\/doi.org\/10.1002\/ptr.70037","DOI":"10.1002\/ptr.70037"},{"key":"4848_CR241","doi-asserted-by":"publisher","unstructured":"Liu S, Jing J, Zhang Y. Potential of herbal formulas and bioactive metabolites in treating atherosclerosis: targeted modulation of macrophage polarization. Front Pharmacol. 2025;16:1631274. https:\/\/doi.org\/10.3389\/fphar.2025.1631274","DOI":"10.3389\/fphar.2025.1631274"},{"key":"4848_CR242","doi-asserted-by":"publisher","first-page":"22968","DOI":"10.1021\/acsnano.5c02492","volume":"19","author":"J Zeng","year":"2025","unstructured":"Zeng J, et al. Biomimetic Ginsenoside Rb1 and Probucol Co-Assembled Nanoparticles for Targeted Atherosclerosis Therapy via Inhibition of Oxidative Stress, Inflammation, and Lipid Deposition. ACS Nano. 2025;19:22968\u201322987. https:\/\/doi.org\/10.1021\/acsnano.5c02492","journal-title":"ACS Nano"},{"issue":"undefined","key":"4848_CR243","doi-asserted-by":"publisher","first-page":"8831750","DOI":"10.1155\/2022\/8831750","volume":"2022","author":"MX Zhang","year":"2022","unstructured":"Zhang MX, Song Y, Xu WL, Zhang LX, Li C, Li YL. Natural Herbal Medicine as a Treatment Strategy for Myocardial Infarction through the Regulation of Angiogenesis. Evid Based Complement Alternat Med. 2022;2022:8831750. https:\/\/doi.org\/10.1155\/2022\/8831750","journal-title":"Evid Based Complement Alternat Med"},{"key":"4848_CR244","doi-asserted-by":"publisher","unstructured":"Mao S, Liang Y, Chen Z,Wang L, Zhang H, Yu L. Adaptive bioactivable nanosystems for synergistic myocardial infarction therapy using traditional pharmaceutics. Bioact Mater 2025; ,54:648\u2013665. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.08.041","DOI":"10.1016\/j.bioactmat.2025.08.041"},{"key":"4848_CR245","doi-asserted-by":"publisher","first-page":"116657","DOI":"10.1016\/j.taap.2023.116657","volume":"476","author":"I Ishtiaq","year":"2023","unstructured":"Ishtiaq I, Zeb A, Badshah H, Alattar A, Alshaman R, Koh PO, Rehman NU, Shah FA, Althobaiti YS. Enhanced cardioprotective activity of ferulic acid-loaded solid lipid nanoparticle in an animal model of myocardial injury. Toxicol Appl Pharmacol. 2023;476:116657. https:\/\/doi.org\/10.1016\/j.taap.2023.116657.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4848_CR246","doi-asserted-by":"publisher","first-page":"e20746","DOI":"10.1016\/j.heliyon.2023.e20746","volume":"9","author":"J Hao","year":"2023","unstructured":"Hao J, Lv A, Li X, Li Y. A Convergent fabrication of silk fibroin nanoparticles on quercetin loaded metal-organic frameworks for promising nanocarrier of myocardial infraction. Heliyon. 2023;9:e20746. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20746.","journal-title":"Heliyon"},{"key":"4848_CR247","doi-asserted-by":"publisher","first-page":"116541","DOI":"10.1016\/j.biopha.2024.116541","volume":"174","author":"M Yao","year":"2024","unstructured":"Yao M, Wu M, Yuan M, Wu M, Shen A, Chen Y, Lian D, Liu X, Peng J. Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study. Biomed Pharmacother. 2024;174:116541. https:\/\/doi.org\/10.1016\/j.biopha.2024.116541.","journal-title":"Biomed Pharmacother"},{"key":"4848_CR248","doi-asserted-by":"publisher","unstructured":"Pozos-Nonato S, Dom\u00ednguez-Delgado CL, Campos-Santander KA, Benavides AA, Pacheco-Ortin SM, Higuera-Piedrahita RI, Resendiz-Gonz\u00e1lez G, Molina-Trinidad EM. Novel Nanotechnological Strategies for Skin Anti-aging Curr Pharm Biotechnol. 2023;24(11):1397\u20131419. https:\/\/doi.org\/10.2174\/1389201024666221223095315.","DOI":"10.2174\/1389201024666221223095315"},{"key":"4848_CR249","doi-asserted-by":"publisher","unstructured":"Song S, Ding L,Liu G,Chen T,Zhao M. The protective effects of baicalin for respiratory diseases: an update and future perspectives. Front Pharmacol. 2023;14:1129817. https:\/\/doi.org\/10.3389\/fphar.2023.1129817.","DOI":"10.3389\/fphar.2023.1129817"},{"issue":"1","key":"4848_CR250","doi-asserted-by":"publisher","first-page":"e1412","DOI":"10.1002\/wnan.1412","volume":"9","author":"J Zhang","year":"2017","unstructured":"Zhang J, Zu Y, Dhanasekara CS, et al Detection and treatment of atherosclerosis using nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(1):e1412. . https:\/\/doi.org\/10.1002\/wnan.1412.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4848_CR251","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2018.10.028","volume":"291","author":"N van Benne","year":"2018","unstructured":"Benne N, van Duijn J, Lozano Vigario F, et al. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. J Control Release. 2018;291:135\u2013146. https:\/\/doi.org\/10.1016\/j.jconrel.2018.10.028","journal-title":"J Control Release"},{"issue":"1","key":"4848_CR252","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12410-009-9002-3","volume":"3","author":"JR McCarthy","year":"2010","unstructured":"McCarthy JR. Nanomedicine and Cardiovascular Disease. Curr Cardiovasc Imaging Rep. 2010;3(1):42\u201349. https:\/\/doi.org\/10.1007\/s12410-009-9002-3","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"13","key":"4848_CR253","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/cvr\/cvaa047","volume":"116","author":"A Zia","year":"2020","unstructured":"Zia A, Wu Y, Nguyen T, Wang X, Peter K, Ta HT. The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis. Cardiovasc Res. 2020;116(13):2055\u20132068. https:\/\/doi.org\/10.1093\/cvr\/cvaa047","journal-title":"Cardiovasc Res"},{"issue":"6","key":"4848_CR254","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1021\/acsnano.7b02308","volume":"11","author":"C Kang","year":"2017","unstructured":"Kang C, Gwon S, Song C, et al. Fibrin-Targeted and H2O2-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels. ACS Nano. 2017;11(6):6194\u20136203. https:\/\/doi.org\/10.1021\/acsnano.7b02308","journal-title":"ACS Nano"},{"issue":"48","key":"4848_CR255","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/eurheartj\/ehz283","volume":"40","author":"E Lutgens","year":"2019","unstructured":"Lutgens E, Atzler D, D\u00f6ring Y, Duchene J, Steffens S, Weber C. Immunotherapy for cardiovascular disease. Eur Heart J. 2019;40(48):3937\u20133946. https:\/\/doi.org\/10.1093\/eurheartj\/ehz283","journal-title":"Eur Heart J"},{"issue":"1","key":"4848_CR256","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12012-025-10074-8","volume":"26","author":"S Ratra","year":"2025","unstructured":"Ratra S, Mukherjee S, Ray S, Yu A, Rengan AK. Inventive HDL Mimicking Nanoparticles: A Promising Frontier in Cardiovascular Disease Management. Cardiovasc Toxicol. 2025;26(1):2. https:\/\/doi.org\/10.1007\/s12012-025-10074-8","journal-title":"Cardiovasc Toxicol"},{"issue":"4","key":"4848_CR257","doi-asserted-by":"publisher","first-page":"045031","DOI":"10.1088\/1748-605X\/abdef8","volume":"16","author":"H Malektaj","year":"2021","unstructured":"Malektaj H, Imani R, Siadati MH. Study of injectable PNIPAAm hydrogels containing niosomal angiogenetic drug delivery system for potential cardiac tissue regeneration. Biomed Mater. 2021;16(4):045031. https:\/\/doi.org\/10.1088\/1748-605X\/abdef8","journal-title":"Biomed Mater"},{"issue":"46","key":"4848_CR258","doi-asserted-by":"publisher","first-page":"e45911","DOI":"10.1097\/MD.0000000000045911","volume":"104","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Yu M, Dang C, Chen H. A review on the research progress of nano-preparations of traditional Chinese medicine for cardiovascular diseases. Med (Baltim). 2025;104(46):e45911. https:\/\/doi.org\/10.1097\/MD.0000000000045911.","journal-title":"Med (Baltim)"},{"key":"4848_CR259","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.amjcard.2026.03.034","volume":"269","author":"SH Hadri","year":"2026","unstructured":"Hadri SH, Tareen N, Javed H, et al. Nanotechnology in Cardiology: A New Era of Targeted Therapies and Advanced Diagnostics-A Review. Am J Cardiol. 2026;269:156\u2013167. https:\/\/doi.org\/10.1016\/j.amjcard.2026.03.034","journal-title":"Am J Cardiol"},{"issue":"1","key":"4848_CR260","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jjcc.2022.02.009","volume":"81","author":"RS Soumya","year":"2023","unstructured":"Soumya RS, Raghu KG. Recent advances on nanoparticle-based therapies for cardiovascular diseases. J Cardiol. 2023;81(1):10\u201318. https:\/\/doi.org\/10.1016\/j.jjcc.2022.02.009","journal-title":"J Cardiol"},{"key":"4848_CR261","doi-asserted-by":"publisher","first-page":"100249","DOI":"10.1016\/j.mtbio.2022.100249","volume":"14","author":"M Karam","year":"2022","unstructured":"Karam M, Fahs D, Maatouk B, Safi B, Jaffa AA, Mhanna R. Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects. Mater Today Bio. 2022;14:100249. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100249.","journal-title":"Mater Today Bio"},{"issue":"2","key":"4848_CR262","doi-asserted-by":"publisher","first-page":"e23424","DOI":"10.1096\/fj.202302001R","volume":"38","author":"P Schelemei","year":"2024","unstructured":"Schelemei P, Wagner E, Picard FSR, Winkels H. Macrophage mediators and mechanisms in cardiovascular disease. FASEB J. 2024;38(2):e23424. https:\/\/doi.org\/10.1096\/fj.202302001R.","journal-title":"FASEB J"},{"key":"4848_CR263","doi-asserted-by":"publisher","first-page":"1000316","DOI":"10.3389\/fphar.2022.1000316","volume":"13","author":"PP Hu","year":"2022","unstructured":"Hu PP, Luo SX, Fan XQ, Li D, Tong XY. Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis. Front Pharmacol. 2022;13:1000316. https:\/\/doi.org\/10.3389\/fphar.2022.1000316.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4848_CR264","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3390\/ijms24065205","volume":"24","author":"P Yang","year":"2023","unstructured":"Yang P, Ren J, Yang L. Nanoparticles in the New Era of Cardiovascular Therapeutics: Challenges and Opportunities. Int J Mol Sci. 2023;24(6):5205. https:\/\/doi.org\/10.3390\/ijms24065205","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4848_CR265","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/1381612827666210701154305","volume":"28","author":"RK Sahoo","year":"2022","unstructured":"Sahoo RK, Singh H, Thakur K, Gupta U, Goyal AK. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases. Curr Pharm Des. 2022;28(2):91\u2013103. https:\/\/doi.org\/10.2174\/1381612827666210701154305.","journal-title":"Curr Pharm Des"},{"issue":"8","key":"4848_CR266","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/pharmaceutics16081037","volume":"16","author":"I Alradwan","year":"2024","unstructured":"Alradwan I, Al Fayez N, Alomary MN, et al. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging. Pharmaceutics. 2024;16(8):1037. https:\/\/doi.org\/10.3390\/pharmaceutics16081037","journal-title":"Pharmaceutics"},{"issue":"4","key":"4848_CR267","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7150\/ntno.62730","volume":"5","author":"Y Wu","year":"2021","unstructured":"Wu Y, Vazquez-Prada KX, Liu Y, Whittaker AK, Zhang R, Ta HT. Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases. Nanotheranostics. 2021;5(4):499\u2013514. https:\/\/doi.org\/10.7150\/ntno.62730.","journal-title":"Nanotheranostics"},{"issue":"6","key":"4848_CR268","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1586\/erc.12.41","volume":"10","author":"ZM Binsalamah","year":"2012","unstructured":"Binsalamah ZM, Paul A, Prakash S, Shum-Tim D. Nanomedicine in cardiovascular therapy: recent advancements. Expert Rev Cardiovasc Ther. 2012;10(6):805\u2013815. https:\/\/doi.org\/10.1586\/erc.12.41","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"4848_CR269","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5334\/gh.1364","volume":"19","author":"MR Miller","year":"2024","unstructured":"Miller MR, Di Cesare M, Rahimzadeh S, et al. Clearing the Air to Address Pollution\u2019s Cardiovascular Health Crisis. Glob Heart. 2024;19(1):82. https:\/\/doi.org\/10.5334\/gh.1364.","journal-title":"Glob Heart"},{"issue":"1","key":"4848_CR270","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12913-021-06146-4","volume":"21","author":"LN Aminde","year":"2021","unstructured":"Aminde LN, Dzudie A, Mapoure YN, Tantchou JC, Veerman JL. Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon. BMC Health Serv Res. 2021;21(1):140. https:\/\/doi.org\/10.1186\/s12913-021-06146-4.","journal-title":"BMC Health Serv Res"},{"key":"4848_CR271","doi-asserted-by":"publisher","first-page":"742315","DOI":"10.3389\/fcvm.2021.742315","volume":"8","author":"SB Alvi","year":"2021","unstructured":"Alvi SB, Ahmed S, Sridharan D, et al. De novo Drug Delivery Modalities for Treating Damaged Hearts: Current Challenges and Emerging Solutions. Front Cardiovasc Med. 2021;8:742315. https:\/\/doi.org\/10.3389\/fcvm.2021.742315.","journal-title":"Front Cardiovasc Med"},{"key":"4848_CR272","doi-asserted-by":"publisher","first-page":"594815","DOI":"10.2147\/IJN.S594815","volume":"21","author":"JJ Zhang","year":"2026","unstructured":"Zhang JJ, Huang YQ, Liu X, Xie P. Plant-Derived Extracellular Vesicles for Nanomedicine in Cardiopulmonary Diseases: A Narrative Review. Int J Nanomed. 2026;21:594815. https:\/\/doi.org\/10.2147\/IJN.S594815.","journal-title":"Int J Nanomed"},{"key":"4848_CR273","doi-asserted-by":"publisher","first-page":"120297","DOI":"10.1016\/j.biomaterials.2020.120297","volume":"258","author":"A Zenych","year":"2020","unstructured":"Zenych A, Fournier L, Chauvierre C. Nanomedicine progress in thrombolytic therapy. Biomaterials. 2020;258:120297. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120297","journal-title":"Biomaterials"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04848-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:31:42Z","timestamp":1786437102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04848-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":273,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4848"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04848-4","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"387"}}